-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q3Fl/bmZJYm/9QFOdHcnbUgOo+26JTBQD47gsF0/wXtZSTW4rbuZMjlvKkD3yUj5 ZIRxmoWLTgARhdJCjY5P8g== 0000904978-08-000039.txt : 20080501 0000904978-08-000039.hdr.sgml : 20080501 20080430175043 ACCESSION NUMBER: 0000904978-08-000039 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20080331 FILED AS OF DATE: 20080501 DATE AS OF CHANGE: 20080430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SUN HEALTHCARE GROUP INC CENTRAL INDEX KEY: 0000904978 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SKILLED NURSING CARE FACILITIES [8051] IRS NUMBER: 850410612 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12040 FILM NUMBER: 08791209 BUSINESS ADDRESS: STREET 1: 101 SUN AVENUE N E CITY: ALBUQUERQUE STATE: NM ZIP: 87109 BUSINESS PHONE: 5058213355 MAIL ADDRESS: STREET 1: 101 SUN LANE N E CITY: ALBUQERQUE STATE: NM ZIP: 87109 10-Q 1 form10-q.htm FORM 10-Q form10-q.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

[ X ]     Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2008

or

[    ]     Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 1-12040

SUN HEALTHCARE GROUP, INC.
(Exact name of Registrant as specified in its charter)

Delaware
85-0410612
(State of Incorporation)
(I.R.S. Employer Identification No.)

18831 Von Karman, Suite 400
Irvine, CA  92612
(949) 255-7100
(Address and telephone number of Registrant)


Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x  No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “accelerated filer, large accelerated filer and smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer              o
Accelerated filer                               x
Non-accelerated filer                o
(Do not check if a smaller reporting company)
Smaller reporting company              o

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   No x

As of April  29, 2008, there were 43,023,204 shares of the Registrant’s $.01 par value Common Stock outstanding.


 
1

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

Index
   
Page
Numbers
PART I.  FINANCIAL INFORMATION
 
     
Item 1.
Financial Statements:
 
     
 
Consolidated Balance Sheets
3 - 4
 
          As of March 31, 2008 (unaudited)
 
 
          As of December 31, 2007
 
     
 
Consolidated Income Statements
5
 
          For the three months ended March 31, 2008 and 2007 (unaudited)
 
     
 
Consolidated Statements of Cash Flows
6
 
          For the three months ended March 31, 2008 and 2007 (unaudited)
 
     
 
Notes to Consolidated Financial Statements
7 - 25
     
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
26 - 36
     
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
37
     
Item 4.
Controls and Procedures
37
     
   
PART II.  OTHER INFORMATION
 
     
Item 1.
Legal Proceedings
37
     
Item 6.
Exhibits
38
     
Signature
 
38

References throughout this document to the “Company,” “Sun,” “we,” “our,” “ours” and “us” refer to Sun Healthcare Group, Inc. and its subsidiaries.

STATEMENT REGARDING FORWARD LOOKING STATEMENTS

Information provided in this Quarterly Report on Form 10-Q (this “10-Q”) contains “forward-looking” information as that term is defined by the Private Securities Litigation Reform Act of 1995 (the “Act”).  All statements regarding our expected future financial position, results of operations, cash flows, integration of the operations of Harborside Healthcare Corporation, indebtedness, lease obligations and liquidity, financing plans, business strategies, budgets, estimates of critical accounting policies, projected costs and capital expenditures, competitive position, growth opportunities, the anticipated impact of changes in Medicare, Medicaid and other governmental reimbursement programs and the impact of regulatory initiatives and government investigations and audits that may affect our business, our ability to defend lawsuits, the ability of our self-insurance programs to satisfy claims, plans of management for future operations and words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” "intend,” “may” and other similar expressions are forward-looking statements.  The forward-looking statements are qualified in their entirety by these cautionary statements, which are being made pursuant to the provisions of the Act and with the intention of obtaining the benefits of the "safe harbor" provisions of the Act.  We do not intend, and undertake no obligation, to update our forward-looking statements to reflect future events or circumstances.

We caution investors that any forward-looking statements made by us are not guarantees of future performance.  Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. Such material differences may result from the factors described in our 2007 Annual Report on Form 10-K (see Item 1A – “Risk Factors”) and other factors that are unknown to us or may be beyond our control.  Such risks should be carefully considered before any investment is made in our securities.  Given these risks and other uncertainties, we can give no assurances that any of the events or circumstances described in our forward-looking statements will in fact transpire, or that the impact of such events or circumstances will be material to our business and financial condition.  Therefore undue reliance should not be placed on such forward-looking statements.
___________________


 
2

 

PART I.     FINANCIAL INFORMATION

ITEM 1.     FINANCIAL STATEMENTS

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

ASSETS
(in thousands)

   
March 31, 2008
   
December 31, 2007
 
   
(Unaudited)
   
(Note 1)
 
Current assets:
           
Cash and cash equivalents
$
62,882
 
$
55,832
 
Restricted cash
 
37,926
   
37,365
 
Accounts receivable, net of allowance for doubtful accounts
           
of $44,069 and $42,144 at March 31, 2008
           
and December 31, 2007, respectively
 
201,082
   
188,882
 
Other receivables, net of allowance for doubtful accounts
           
of $1,587 and $1,587 at March 31, 2008 and
           
December 31, 2007, respectively
 
1,256
   
1,635
 
Prepaid expenses and other assets
 
16,206
   
11,655
 
Assets held for sale
 
10,727
   
9,924
 
Deferred tax assets
 
36,579
   
35,354
 
             
Total current assets
 
366,658
   
340,647
 
             
Property and equipment, net of accumulated depreciation and
           
amortization of $86,155 and $77,028 at March 31, 2008 and
           
December 31, 2007, respectively
 
583,090
   
585,972
 
Intangible assets, net of accumulated amortization of $8,415 and
           
$6,729 at March 31, 2008 and December 31, 2007,
           
respectively
 
55,347
   
57,044
 
Goodwill
 
324,277
   
324,277
 
Restricted cash, non-current
 
3,263
   
3,829
 
Deferred tax assets
 
48,838
   
51,892
 
Other assets
 
6,475
   
10,165
 
             
Total assets
$
1,387,948
 
$
1,373,826
 


See accompanying notes.


 
3

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (CONTINUED)

LIABILITIES AND STOCKHOLDERS’ EQUITY
(in thousands, except share data)

   
March 31, 2008
   
December 31, 2007
 
   
(Unaudited)
   
(Note 1)
 
Current liabilities:
           
Accounts payable
$
51,246
 
$
52,836
 
Accrued compensation and benefits
 
63,070
   
61,956
 
Accrued self-insurance obligations, current portion
 
51,365
   
48,646
 
Income taxes payable
 
3,480
   
3,000
 
Liabilities held for sale
 
3,411
   
3,181
 
Other accrued liabilities
 
64,500
   
58,002
 
Current portion of long-term debt and capital lease obligations:
           
Company obligations
 
30,979
   
28,480
 
Clipper partnerships
 
845
   
825
 
             
Total current liabilities
 
268,896
   
256,926
 
             
Accrued self-insurance obligations, net of current portion
 
105,766
   
106,534
 
Long-term debt and capital lease obligations, net of current portion:
           
Company obligations
 
646,120
   
651,403
 
Clipper partnerships
 
48,336
   
48,560
 
Unfavorable lease obligations, net of accumulated amortization
           
of $14,611 and $13,799 at March 31, 2008 and
           
December 31, 2007, respectively
 
18,148
   
18,960
 
Other long-term liabilities
 
45,725
   
44,717
 
             
Total liabilities
 
1,132,991
   
1,127,100
 
             
Commitments and contingencies (Note 8)
           
             
Minority interest
 
577
   
470
 
             
Stockholders’ equity:
           
Preferred stock of $.01 par value, authorized 10,000,000
           
shares, no shares were issued or outstanding as of
           
March 31, 2008 and December 31, 2007
 
-
   
-
 
Common stock of $.01 par value, authorized 125,000,000 
           
shares; 43,022,398 and 43,016,042 shares issued and
           
outstanding as of March 31, 2008 and December 31, 2007,
           
respectively
 
430
   
430
 
Additional paid-in capital
 
601,467
   
600,199
 
Accumulated deficit
 
(343,393
)
 
(351,970
)
Accumulated other comprehensive loss, net
 
(4,124
)
 
(2,403
)
   
254,380
   
246,256
 
             
Total liabilities and stockholders’ equity
$
1,387,948
 
$
1,373,826
 





See accompanying notes.

 
4

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED INCOME STATEMENTS
(in thousands, except per share data)


   
For the
 
   
Three Months Ended
 
   
March 31, 2008
   
March 31, 2007
 
   
(Unaudited)
   
(Unaudited)
 
             
Total net revenues
$
458,242
 
$
262,576
 
Costs and expenses:
           
Operating salaries and benefits
 
258,737
   
152,275
 
Self-insurance for workers’ compensation and general and
           
professional liability insurance
 
15,202
   
10,289
 
Operating administrative expenses
 
11,939
   
7,591
 
Other operating costs
 
95,420
   
52,145
 
Center rent expense
 
18,804
   
13,429
 
General and administrative expenses
 
16,586
   
12,832
 
Depreciation and amortization
 
9,709
   
3,876
 
Provision for losses on accounts receivable
 
3,363
   
2,148
 
Interest, net of interest income of $545 and $1,186, respectively
 
14,431
   
2,062
 
(Gain) loss on sale of assets
 
(77
)
 
8
 
Total costs and expenses
 
444,114
   
256,655
 
             
Income before income taxes and discontinued operations
 
14,128
   
5,921
 
Income tax expense
 
5,654
   
2,368
 
Income from continuing operations
 
8,474
   
3,553
 
             
Discontinued operations:
           
Income from discontinued operations, net of related taxes
 
165
   
720
 
Loss on disposal of discontinued operations, net of related
           
taxes
 
(62
)
 
(350
)
Income from discontinued operations, net
 
103
   
370
 
             
Net income
$
8,577
 
$
3,923
 
             
Basic earnings per common and common equivalent share:
           
Income from continuing operations
$
0.20
 
$
0.08
 
Income from discontinued operations, net
 
-
   
0.01
 
Net income
$
0.20
 
$
0.09
 
             
Diluted earnings per common and common equivalent share:
           
Income from continuing operations
$
0.19
 
$
0.08
 
Income from discontinued operations, net
 
-
   
0.01
 
Net income
$
0.19
 
$
0.09
 
             
Weighted average number of common and common
           
equivalent shares outstanding:
           
Basic
 
43,067
   
42,908
 
Diluted
 
44,474
   
44,029
 

See accompanying notes.

 
5

 

SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

   
For the
 
   
Three Months Ended
 
   
March 31, 2008
   
March 31, 2007
 
   
(Unaudited)
   
(Unaudited)
 
Cash flows from operating activities:
           
Net income
$
8,577
 
$
3,923
 
Adjustments to reconcile net income to net cash provided by
           
operating activities, including discontinued operations:
           
Depreciation and amortization
 
9,717
   
3,956
 
Amortization of favorable and unfavorable lease intangibles
 
(503
)
 
(213
)
Provision for losses on accounts receivable
 
3,301
   
2,523
 
(Gain) loss on sale of assets, including discontinued operations, net
 
(15
)
 
357
 
Stock-based compensation expense
 
965
   
750
 
Deferred taxes
 
1,829
   
-
 
Minority interest
 
107
   
-
 
Other
 
-
   
2
 
Changes in operating assets and liabilities:
           
Accounts receivable
 
(15,501
)
 
(2,050
)
Other receivables
 
368
   
537
 
Restricted cash
 
5
   
721
 
Prepaid expenses and other assets
 
(5,702
)
 
(6,558
)
Assets and liabilities held for sale
 
(528
)
 
-
 
Accounts payable
 
(1,598
)
 
(3,925
)
Accrued compensation and benefits
 
1,114
   
(1,666
)
Accrued self-insurance obligations
 
1,951
   
(846
)
Income taxes payable
 
470
   
2,426
 
Other accrued liabilities
 
6,528
   
1,230
 
Other long-term liabilities
 
1,679
   
404
 
Net cash provided by operating activities
 
12,764
   
1,571
 
             
Cash flows from investing activities:
           
Capital expenditures
 
(5,916
)
 
(7,250
)
Proceeds from sale of assets held for sale
 
3,777
   
3,238
 
Acquisitions
 
(307
)
 
-
 
Net cash used for investing activities
 
(2,446
)
 
(4,012
)
             
Cash flows from financing activities:
           
Net borrowings under Credit Agreement
 
-
   
6
 
Long-term debt repayments
 
(2,820
)
 
(29,607
)
Principal payments under capital lease obligations
 
(264
)
 
(540
)
Proceeds from issuance of common stock
 
39
   
573
 
Distribution of partnership equity
 
(223
)
 
(256
)
Net cash used for financing activities
 
(3,268
)
 
(29,824
)
             
Net increase (decrease) in cash and cash equivalents
 
7,050
   
(32,265
)
Cash and cash equivalents at beginning of period
 
55,832
   
131,935
 
Cash and cash equivalents at end of period
$
62,882
 
$
99,670
 




See accompanying notes.

 
6

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)


(1)  Nature of Business

References throughout this document to the Company include Sun Healthcare Group, Inc. and our consolidated subsidiaries. In accordance with the Securities and Exchange Commission’s “Plain English” guidelines, this report has been written in the first person. In this document, the words “we,” “our,” “ours,” and “us” refer to Sun Healthcare Group, Inc. and its direct and indirect consolidated subsidiaries and not any other person.

Business

Our subsidiaries provide long-term, subacute and related specialty healthcare in the United States.  We operate through three principal business segments: (i) inpatient services, (ii) rehabilitation therapy services, and (iii) medical staffing services.  Inpatient services represent the most significant portion of our business.  We operated 213 long-term care centers in 25 states as of March 31, 2008.

Other Information

The accompanying unaudited consolidated financial statements have been prepared in accordance with our customary accounting practices and accounting principles generally accepted in the United States for interim financial statements.  In our opinion, the accompanying interim consolidated financial statements are a fair statement of our financial position at March 31, 2008, and the consolidated results of our operations and cash flows for the three-month periods ended March 31, 2008 and 2007, respectively.  These statements are unaudited, and certain information and footnote disclosures normally included in our annual consolidated financial statements have been condensed or omitted, as permitted under the applicable rules and regulations. Readers of these statements should refer to our audited consolidated financial statements and notes thereto for the year ended December 31, 2007, which are included in our Annual Report on Form 10-K for the year ended December 31, 2007 (the “2007 Form 10-K”).

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include determination of third-party payor settlements, allowances for doubtful accounts, self-insurance obligations, loss accruals, and income taxes. Actual results could differ from those estimates.

Recent Accounting Pronouncements

In March 2008, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards No. 161, Disclosures About Derivative Instruments and Hedging Activities – an amendment of FASB Statement No. 133 (“SFAS No. 161”), which expands quarterly disclosure requirements in Statement of Financial Accounting Standards No. 133, Accounting for Derivative Instruments and Hedging Activity (“SFAS No. 133”), about an entity’s derivative instruments and hedging activities. SFAS No. 161 is effective for fiscal years beginning after November 15, 2008.  We are currently assessing the impact of SFAS No. 161 on our consolidated financial position and results of operations.

Reclassifications and Adjustments

Certain reclassifications have been made to the prior period financial statements to conform to the 2008 financial statement presentation.  Specifically, we have reclassified the results of operations of certain centers held for sale (see Note 6 – “Discontinued Operations and Assets and Liabilities Held for Sale”) for all periods presented to discontinued operations within the income statement, in accordance with accounting principles generally accepted in the United States.


 
7

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)


(2)  Acquisition

On April 19, 2007, we acquired Harborside Healthcare Corporation (“Harborside”), a privately-held healthcare company based in Boston, Massachusetts that operated 73 skilled nursing centers, one assisted living center and one independent living center with approximately 9,000 licensed beds in ten states.  The application of purchase accounting in accordance with Statement of Financial Accounting Standards No. 141, Business Combinations, was completed as of March 31, 2008.

The following unaudited summarized pro forma results of operations for the three months ended March 31, 2007 assume that the Harborside acquisition occurred at the beginning of the period (information for the three months ended March 31, 2008 are the actual results of operation for that period).  The unaudited pro forma results are not necessarily indicative of the actual results of operations that would have been achieved, nor are they necessarily indicative of future results of operations (in thousands, except per share data):

   
For the Three Months Ended
 
   
March 31, 2008
   
March 31, 2007
 
   
(actual)
   
(pro forma)
 
             
Revenues
$
458,242
 
$
425,143
 
Costs and expenses:
           
Operating costs
 
366,096
   
342,914
 
Center rent expense
 
18,804
   
20,383
 
Depreciation and amortization
 
9,709
   
8,628
 
Interest, net
 
14,431
   
6,706
 
Non-operating costs
 
35,074
   
42,713
 
Total costs and expenses
 
444,114
   
421,344
 
             
Income before income taxes and
           
discontinued operations
 
14,128
   
3,799
 
Income tax expense
 
5,654
   
1,548
 
Income from continuing operations
 
8,474
   
2,251
 
Income (loss) from discontinued operations, net
 
103
   
(195
)
Net income
$
8,577
 
$
2,056
 
             
Earnings per share:
           
Basic:
           
Income from continuing operations
$
0.20
 
$
0.05
 
Net income
$
0.20
 
$
0.05
 
             
Diluted:
           
Income from continuing operations
$
0.19
 
$
0.05
 
Net income
$
0.19
 
$
0.05
 

(3)  Loan Agreements

We have issued $200.0 million aggregate principal amount of 9-1/8% Senior Subordinated Notes (the “Notes”). The Notes, of which $200.0 million remain outstanding, are unconditionally guaranteed on a senior subordinated basis by certain of our subsidiaries and are unsecured by any assets (see Note 12 – “Summarized Consolidating Information”).  The Notes mature on April 15, 2015, and we are entitled to redeem some or all of the Notes at any time on or after April 15, 2011 at certain pre-specified redemption prices.  In addition, prior to April 15, 2011, we may redeem some or all of the Notes at a price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, plus a “make whole” premium as per the terms of the Notes.  We are entitled to redeem up to 35% of the aggregate principal amount of the Notes until April 15, 2010 with the net proceeds from certain equity offerings at certain pre-specified redemption prices.  The Notes accrue interest at an annual rate of 9-1/8%.  The Notes pay interest semi-annually on April 15th and October 15th of each year through the April 15, 2015 maturity date.
 
8

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)


We have entered into a Credit Agreement with a group of lenders for which Credit Suisse acts as administrative agent and collateral agent (the “Credit Agreement”).  The Credit Agreement, which is collateralized by substantially all of our assets, provides for $365.0 million in term loans (all of which have been funded and $349.0 million of which is outstanding as of March 31, 2008 - see Note 4 – “Long-Term Debt and Capital Lease Obligations”), a $50.0 million revolving credit facility and a $70.0 million letter of credit facility.  The final maturity date of the term loans is April 19, 2014, and the revolving credit facility and letter of credit facility terminate on April 19, 2013.  Availability of amounts under the revolving credit facility is subject to compliance with financial covenants including an interest coverage test, a total leverage covenant and a senior leverage covenant.  The Credit Agreement contains customary events of default, such as our failure to make payment of amounts due, defaults under other agreements evidencing indebtedness, certain bankruptcy events and a change of control (as defined in the Credit Agreement). The Credit Agreement also contains customary covenants restricting, among other things, incurrence of indebtedness, liens, payment of dividends, repurchase of stock, acquisitions and dispositions, mergers and investments.

Amounts borrowed under the term loan facilities are due in quarterly installments of 0.25% of the aggregate principal amount of the term loans under the term loan facility outstanding as of January 15, 2008, with the remaining principal amount due on the maturity date of the term loans.  Accrued interest is payable at the end of an interest period, but no less frequently than every three months.  The loans under the Credit Agreement bear interest on the outstanding unpaid principal amount at a rate equal to an applicable percentage plus, at our option, either (a) an alternative base rate determined by reference to the higher of (i) the prime rate announced by Credit Suisse and (ii) the federal funds rate plus one-half of 1.0%, or (b) the London Interbank Offered Rate (“LIBOR”), adjusted for statutory reserves.  The applicable percentage for term loans is 1.0% for alternative base rate loans and 2.0% for LIBOR loans; and the applicable percentage for revolving loans is up to 1.0% for alternative base rate revolving loans and up to 2.0% for LIBOR rate revolving loans based on our total leverage ratio.   Each year, commencing in 2009, within 90 days of the prior fiscal year end, we are required to prepay a portion of the term loans in an amount based on the prior year’s excess cash flows, if any, as defined in the Credit Agreement.

We have entered into an interest rate swap agreement for interest rate risk management purposes.  The interest rate swap agreement effectively modifies our exposure to increases in interest rates by converting a portion of our floating rate debt to a fixed rate.  This agreement involves the receipt of floating rate amounts in exchange for fixed rate interest payments over the life of the agreement without an exchange of the underlying principal amount.  The agreement is based on a notional amount of $100.0 million and terminates in July 2010.  Settlement occurs on a quarterly basis, which is based upon a floating rate of LIBOR and an annual fixed rate of 5.388%.  At March 31, 2008, and December 31, 2007, the fair value of the interest rate swap agreement was a liability of $6.9 million and $4.0 million, respectively, which is based upon quoted prices in active markets for similar arrangements.

The interest rate swap agreement qualifies for hedge accounting treatment under SFAS No. 133 and has been designated as a cash flow hedge.  Hedge effectiveness testing for the three months ended March 31, 2008, indicates that the swap is a fully effective hedge and as such, the derivative mark-to-market adjustment increased our other comprehensive loss by $1.7 million, net of related tax benefit.  The full balance of accumulated other comprehensive loss is due to accounting for our interest rate swap.  We do not anticipate any of this amount to be reclassified into earnings within the next year.  Also, since the swap is a fully effective hedging arrangement, there is no amount related to hedging ineffectiveness to expense.

Our net long-term debt of $726.3 million includes $49.2 million of debt of our nine partnerships and limited liability companies (collectively known as “Clipper”). We own 34% of the equity interests of Clipper, but due to our consolidation of the Clipper entities as variable interest entities, we include all of the Clipper indebtedness on our balance sheet (see Note 7 – “Variable Interest Entities”).  Of the $31.8 million current portion of long-term debt as of March 31, 2008, $0.8 million represents Clipper debt.


 
9

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)


(4)  Long-Term Debt and Capital Lease Obligations

Long-term debt and capital lease obligations consisted of the following as of the periods indicated (in thousands):

   
March 31, 2008
   
December 31, 2007
 
             
Revolving credit agreement
$
-
 
$
-
 
Mortgage notes payable due at various dates through 2037, interest at rates
           
from 5.5% to 10.9%, collateralized by various centers (1)(2)(3)
 
175,737
   
177,712
 
Term loan agreement
 
348,983
   
349,857
 
Senior subordinated notes
 
200,000
   
200,000
 
Capital leases (3)
 
1,560
   
1,699
 
Total long-term obligations
 
726,280
   
729,268
 
Less amounts due within one year
 
(31,824
)
 
(29,305
)
Long-term obligations, net of current portion
$
694,456
 
$
699,963
 

(1)
Includes fair value premium of $0.2 million related to the acquisition of Peak Medical Corporation (“Peak”) in December 2005 and $0.6 million related to the acquisition of Harborside in April 2007.
(2)
Includes $49.2 million and $49.4 million related to the consolidation of Clipper as of March 31, 2008 and December 31, 2007, respectively (see Note 7 – “Variable Interest Entities”).
(3)
Excludes $0.8 million, at December 31, 2007, reclassified to liabilities held for sale (see Note 6 – “Discontinued Operations and Assets and Liabilities Held for Sale”).

The scheduled or expected maturities of long-term obligations, excluding premiums, as of March 31, 2008, were as follows (in thousands):

     
2009
$
31,824
2010
 
7,845
2011
 
15,738
2012
 
36,501
2013
 
7,648
Thereafter
 
625,983
 
$
725,539

Included in the expected maturities of long-term debt are the following amounts related to the consolidation of Clipper (in thousands):  $845, $902, $962, $1,020, $1,095, and $44,357 for 2009, 2010, 2011, 2012, 2013 and thereafter, respectively (see Note 7 – “Variable Interest Entities”).

(5)  Fair Value of Financial Instruments

Statement of Financial Accounting Standards No. 157, Fair Value Measurements (“SFAS No. 157”), establishes a common definition for fair value to be applied to U.S. generally accepted accounting principles requiring use of fair value, establishes a framework for measuring fair value, and expands disclosures about such fair value measurements.  Issued in February 2008, FASB Staff Position No. 157-1, Application of FASB Statement No. 157 to FASB Statement No. 13 and Other Accounting Pronouncements That Address Fair Value Measurements for Purposes of Lease Classification or Measurement under Statement 13, removed leasing transactions accounted for under Statement No. 13 and related guidance from the scope of SFAS No. 157.  FSP No. 157-2, Partial Deferral of the Effective Date of Statement 157, deferred the effective date of SFAS No. 157 for all nonfinancial assets and nonfinancial liabilities to fiscal years beginning after November 15, 2008.

 
10

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)



We adopted SFAS No. 157 as of January 1, 2008 for financial assets and financial liabilities. There was no material impact on our consolidated financial position and results of operations for the three months ended March 31, 2008.  We are currently assessing the impact of SFAS No. 157 for nonfinancial assets and nonfinancial liabilities on our consolidated financial position and results of operations.

SFAS No. 157 establishes a hierarchy for ranking the quality and reliability of the information used to determine fair values.  The statement requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:       
 
Level 1:
Unadjusted quoted market prices in active markets for identical assets or liabilities.

 
Level 2:
Unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.
 
Level 3:
Unobservable inputs for the asset or liability.

We endeavor to utilize the best available information in measuring fair value.  Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement.  We have determined that the $6.9 million long-term liability for our instrument rate swap agreement is level 2 in the fair value hierarchy above.  A portion of our restricted cash, $1,261, is in money market funds, which qualifies for Level 1 in the fair value hierarchy above.  We currently have no other financial instruments subject to fair value measurement on a recurring basis.

(6) Discontinued Operations and Assets and Liabilities Held for Sale

(a) Discontinued Operations

In accordance with the provisions of Statement of Financial Accounting Standards No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets (“SFAS No. 144”), the results of operations of assets to be disposed of, disposed assets and the gains (losses) related to these divestitures have been classified as discontinued operations for all periods presented in the accompanying consolidated income statements.

Inpatient Services: During 2007, we reclassified two hospitals and one skilled nursing center into discontinued operations because they qualified as assets held for sale. In the first quarter of 2007, we sold a skilled nursing center that was classified as held for sale since 2006 for $4.9 million and recorded a net loss of $0.5 million.

Other discontinued operations are principally comprised of the operations of a regional provider of adolescent rehabilitation and special education services.

(b) Assets and Liabilities Held for Sale

As of March 31, 2008, assets held for sale consisted of (i) a skilled nursing center with a net carrying amount of $0.5 million, primarily consisting of property and equipment, (ii) two hospitals with a net carrying amount of $5.9 million, consisting of $9.2 million in assets, offset in part by $3.3 million in liabilities, and (iii) an undeveloped parcel of land valued at $0.9 million, which is classified in our Corporate segment in our consolidated financial statements.


 
11

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)


A summary of the discontinued operations for the periods presented is as follows (in thousands):

   
For the Three Months Ended
 
   
March 31, 2008
 
   
Inpatient
     
Laboratory/
   
Home
             
   
Services
     
Radiology
   
Health
   
Other
   
Total
 
                                 
Net operating revenues
$
12,135
   
$
-
 
$
-
 
$
4,319
 
$
16,454
 
                                 
Income (loss) from discontinued
                               
operations, net (1)
$
544
   
$
(43
)
$
36
 
$
(372
)
$
165
 
(Loss) gain on disposal of
                               
discontinued operations, net (2)
 
(16
)
   
-
   
(47
)
 
1
   
(62
)
Income (loss) from discontinued
                               
operations, net
$
528
   
$
(43
)
$
(11
)
$
(371
)
$
103
 

(1)  Net of related tax expense of $129
(2)  Net of related tax expense of $10

   
For the Three Months Ended
 
   
March 31, 2007
 
   
Inpatient
   
Laboratory/
   
Home
             
   
Services
   
Radiology
   
Health
   
Other
   
Total
 
                               
Net operating revenues
$
13,807
 
$
4,120
 
$
-
 
$
4,139
 
$
22,066
 
                               
Income from discontinued
                             
operations, net (1)
$
374
 
$
236
 
$
5
 
$
105
 
$
720
 
Loss (income) on disposal of
                             
discontinued operations, net (2)
 
(376
)
 
-
   
41
   
(15
)
 
(350
)
Income (loss) from discontinued
                             
operations, net
$
(2
)
$
236
 
$
46
 
$
90
 
$
370
 

 
(1)  Net of related tax benefit of $43
  (2)  Net of related tax benefit of $190

(7)  Variable Interest Entities

The FASB revised Interpretation No. 46, Consolidation of Variable Interest Entities (“FIN No. 46(R)”), which provides guidance on the consolidation of certain entities when control exists through means other than ownership of voting (or similar) interests and requires consolidation by the majority holder of expected residual gains and losses of the activities of a variable interest entity (“VIE”).

As of March 31, 2008, we owned 34% of the voting interest (15.5% at March 31, 2007) in the nine Clipper entities, each of which owns one center that we operate in New Hampshire. Clipper’s objective is to achieve rental income from the leasing of its centers. In April 2004, we entered into an agreement with the owners of the remaining interests in those nine entities.  That agreement granted us options, exercisable sequentially over a period of seven years, pursuant to which we can acquire 100% of the ownership of those nine entities for an aggregate amount of up to $10.3 million, of which we have paid an aggregate of $3.0 million through March 31, 2008.  The agreement also provides the owners the right to require us to purchase those ownership interests at the above described option prices.  These put rights can be exercised for any options that have come due but which were not exercised up to that point in time, but no later than December 31, 2010.

We have concluded that Clipper meets the definition of a VIE because we have agreements with the majority owners granting to us the option to acquire, and to the owners, the right to put to us, 100% ownership of Clipper. We have recognized $5.3 million of the option value in other long-term liabilities in our consolidated balance sheets.  The remaining $2.0 million is recorded as current in other accrued liabilities in our consolidated balance sheets.  We have not recorded any minority interest associated with the 66% interest in which we do not own since the partnerships’ net equity was a deficit

 
12

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

 
and as the primary beneficiary, we would be responsible for all of their losses. Pursuant to FIN No. 46(R), we have eliminated center rent expense of $0.7 million and $0.4 million for each of the three months ended March 31, 2008 and 2007, respectively, and included $49.2 million and $49.4 million of mortgage debt of Clipper in our consolidated balance sheets as of March 31, 2008 and December 31, 2007, respectively, although we own 34% of the voting interest in the Clipper properties and are not directly obligated on the debt. The debt is collateralized by the fixed assets of the respective partnerships and limited liability companies that own the Clipper properties and none of our assets.  Creditors do not have any general recourse against us for the mortgage debt.

The following provides the balance sheet impact of Clipper upon consolidation as of March 31, 2008 and December 31, 2007 (in thousands):

   
March 31, 2008
   
December 31, 2007
 
             
Current assets:
           
Cash and cash equivalents
$
528
 
$
592
 
Restricted cash, current
 
1,842
   
1,588
 
Prepaids and other assets
 
57
   
130
 
Total current assets
 
2,427
   
2,310
 
             
Property and equipment, net:
           
Land
 
6,171
   
6,171
 
Land improvements
 
28
   
29
 
Buildings
 
33,915
   
34,133
 
Building improvements
 
2,746
   
2,835
 
Equipment
 
150
   
153
 
Construction in progress
 
3
   
-
 
Total property and equipment, net
 
43,013
   
43,321
 
             
Intangible assets, net
 
6,487
   
7,014
 
Intercompany
 
4,836
   
4,836
 
             
Total assets
$
56,763
 
$
57,481
 
             
Current liabilities:
           
Mortgages, current
$
845
 
$
825
 
Other accrued liabilities
 
2,192
   
2,224
 
Total current liabilities
 
3,037
   
3,049
 
             
Mortgages, net of current
 
48,336
   
48,560
 
Other long-term liabilities
 
14,708
   
15,163
 
Total long-term liabilities
 
63,044
   
63,723
 
             
Total liabilities
 
66,081
   
66,772
 
             
Stockholders’ deficit:
           
Accumulated deficit
 
(9,318
)
 
(9,291
)
             
Total liabilities and stockholders’ deficit
$
56,763
 
$
57,481
 

For the three months ended March 31, 2008, the consolidation of Clipper included a net loss of $0.3 million comprised of a $0.8 million charge to interest expense, and a $0.3 million charge to depreciation expense, partially offset by a $0.7 million credit to rent expense and a $0.1 million credit to taxes and other expense. For the three months ended March 31, 2007, the consolidation of Clipper included a net loss of $0.5 million comprised of a $0.6 million charge to interest expense, and a $0.4 million charge to depreciation expense, partially offset by a $0.4 million credit to rent expense and a $0.1 million credit to taxes and other expense.

 
13

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)


(8)  Commitments and Contingencies

Insurance

Since January 2000, we have relied upon self-funded insurance programs for general and professional liability claims ($5.0 million per claim since January 1, 2004), which amounts we are responsible for funding, and we have maintained excess insurance policies for claims above those amounts. The Harborside operations, which we acquired in April 2007, and the Peak operations, which we acquired in December 2005, utilized several different general and professional insurance programs.  We have added the Harborside and Peak operations to our general and professional liability programs.  Insurance coverage for punitive damages arising from general and professional liability litigation may not be available due to state law public policy prohibitions and our insurance coverages. There can be no assurance that we will not be liable for punitive damages awarded in litigation in which insurance coverage is not available.

With the exception of state-controlled workers’ compensation plans, our workers’ compensation risks are insured through high-retention insurance policies with third parties.

We evaluate the adequacy of our self-insurance reserves on a quarterly basis and perform actuarial analyses semi-annually in the second and fourth quarters. The analyses use generally accepted actuarial methods in evaluating the workers’ compensation reserves and general and professional liability reserves.  For both the workers’ compensation reserves and the general and professional liability reserves, those methods include reported and paid loss development methods, expected loss method and the reported and paid Bornhuetter-Ferguson methods.  The foundation for each of these methods is our actual historical reported and/or paid loss data.  In cases where our historical data is not statistically credible, stable, or mature, we supplement our experience with industry benchmark reporting and payment patterns. The use of multiple methods tends to eliminate any biases that one particular method might have. The results of each of the methods is an estimate of ultimate losses which includes the case reserves plus an estimate for future development of these reserves based on past trends, and an estimate for losses incurred but not reported.   These results are compared by accident year and an estimated unpaid loss and allocated loss adjustment expense is determined for the open accident years based on judgment reflecting the range of estimates produced by the methods.

Activity in our insurance reserves as of and for the three months ended March 31, 2008 and 2007 is as follows (in thousands):

   
Professional
   
Workers’
       
   
Liability
   
Compensation
   
Total
 
                   
Balance as of January 1, 2007
$
75,078
 
$
51,521
 
$
126,599
 
Current year provision, continuing operations
 
6,305
   
3,984
   
10,289
 
Current year provision, discontinued operations
 
234
   
313
   
547
 
Claims paid, continuing operations
 
(1,849
)
 
(2,276
)
 
(4,125
)
Claims paid, discontinued operations
 
(2,938
)
 
(1,172
)
 
(4,110
)
Amounts paid for administrative services and other
 
(1,963
)
 
(1,063
)
 
(3,026
)
Balance as of March 31, 2007
$
74,867
 
$
51,307
 
$
126,174
 
                   
Balance as of January 1, 2008
$
86,291
 
$
61,439
 
$
147,730
 
Current year provision, continuing operations
 
8,647
   
6,555
   
15,202
 
Current year provision, discontinued operations
 
139
   
172
   
311
 
Claims paid, continuing operations
 
(4,308
)
 
(4,673
)
 
(8,981
)
Claims paid, discontinued operations
 
(1,066
)
 
(693
)
 
(1,759
)
Amounts paid for administrative services and other
 
(1,052
)
 
(2,026
)
 
(3,078
)
Balance as of March 31, 2008
$
88,651
 
$
60,774
 
$
149,425
 
                   


 
14

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)


A summary of the assets and liabilities related to insurance risks at March 31, 2008 and December 31, 2007 is as indicated (in thousands):

   
March 31, 2008
     
December 31, 2007
 
   
Professional
   
Workers’
       
|
 
Professional
   
Workers’
       
   
Liability
   
Compensation
   
Total
 
|
 
Liability
   
Compensation
   
Total
 
Assets (1):
                 
|
                 
Restricted cash
                 
|
                 
Current
$
3,593
 
$
20,764
 
$
24,357
 
|
$
3,717
 
$
20,933
 
$
24,650
 
Non-current
 
-
   
-
   
-
 
|
 
-
   
566
   
566
 
Total
$
3,593
 
$
20,764
 
$
24,357
 
|
$
3,717
 
$
21,499
 
$
25,216
 
                   
|
                 
Liabilities (2)(3):
                 
|
                 
Self-insurance
                 
|
                 
Liabilities
                 
|
                 
Current
$
20,479
 
$
23,180
 
$
43,659
 
|
$
20,263
 
$
20,933
 
$
41,196
 
Non-current
 
68,172
   
37,594
   
105,766
 
|
 
66,028
   
40,506
   
106,534
 
Total
$
88,651
 
$
60,774
 
$
149,425
 
|
$
86,291
 
$
61,439
 
$
147,730
 

(1)
 
Total restricted cash above excludes $16,832 and $15,978 at March 31, 2008 and December 31, 2007, respectively, held for bank collateral, various mortgages, bond payments and capital expenditures on HUD insured buildings.
     
(2)
 
Total self-insurance liabilities in the table excludes $7,706 and $7,450 at March 31, 2008 and December 31, 2007, respectively, related to our health insurance liabilities.
     
(3)
 
Total self-insurance liabilities are collateralized, in addition to the restricted cash, by letters of credit of $750 and $50,619 for general and professional liability insurance and workers’ compensation, respectively, as of March 31, 2008 and as of December 31, 2007.

(9)  Income Taxes

The provision for income taxes was based upon our estimate of taxable income or loss for each respective accounting period.  We recognized an asset or liability for the deferred tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts in the financial statements.  These temporary differences would result in taxable or deductible amounts in future years when the reported amounts of the assets are recovered or liabilities are settled.  We also recognized as deferred tax assets the future tax benefits from net operating loss (“NOL”) and tax credit carryforwards.

A valuation allowance of $132.9 million has been provided for deferred tax assets.  The realization of deferred tax assets is dependent upon generation of future taxable income during those periods in which temporary differences become deductible and/or credits can be utilized.  As a result, we consider the level of historical taxable income, historical non-recurring credits and charges, the scheduled reversal of deferred tax liabilities, tax-planning strategies and projected future taxable income.  Based on these considerations, we believe that a reduction of some or all of the valuation allowance may be possible by the end of 2008 if appropriate levels of profitability are attained.

Any reduction in the portion of the valuation allowance that was established in fresh-start accounting when we emerged from bankruptcy in February 2002 ($55.9 million) would increase additional paid-in capital.  Any reduction in the portion of the valuation allowance that was established after our emergence from bankruptcy ($77.0 million) would result in a reduction of our income tax expense.  There was no change in the valuation allowance during the first quarter of 2008.

The provision for income taxes of $5.7 million for the three months ended March 31, 2008 is based on a combined federal and state income tax rate of approximately 40%.  The provision for income taxes of $2.4 million for the three months ended March 31, 2007 was also based on a combined income tax rate of approximately 40%.

 
15

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)



Internal Revenue Code (“IRC”) Section 382 imposes a limitation on the use of a company’s NOL carryforwards and other losses when the company has an ownership change.  In general, an ownership change occurs when shareholders owning 5% or more of a “loss corporation” (a corporation entitled to use NOL or other loss carryovers) have increased their ownership of stock in such corporation by more than 50 percentage points during any three-year testing period beginning on the first day following the change date for an earlier ownership change.  The annual base IRC Section 382 limitation is calculated by multiplying the loss corporation’s value at the time of the ownership change times the greater of the long-term tax-exempt rate determined by the Internal Revenue Service (“IRS”) in the month of the ownership change or the two preceding months.

The issuance of our common stock in connection with the acquisition of Peak in 2005 resulted in an ownership change under IRC Section 382.  The annual base IRC Section 382 limitation to be applied to our tax attribute carryforwards as a result of this ownership change is approximately $10.3 million.  Accordingly, our NOL, capital loss, and tax credit carryforwards have been reduced to take into account this limitation and the respective carryforward periods for these tax attributes.  In addition, a separate annual base IRC Section 382 limitation of approximately $14.6 million is to be applied to the tax attribute carryforwards of Harborside as a result of our acquisition of Harborside.  As a result of unused IRC Section 382 limitations from prior years and post-ownership change NOLs, there is approximately $107.0 million of NOLs which can be used to offset U.S. taxable income in 2008.

Our application of the rules under IRC Section 382 is subject to challenge upon IRS audit.  A successful challenge could significantly impact our ability to utilize deductions, losses and tax credits generated prior to the dates of the Peak and Harborside acquisitions.

After considering the reduction in tax attributes from the IRC Section 382 limitations resulting from the Peak and Harborside acquisitions, we have federal NOL carryforwards of approximately $265.8 million with expiration dates from 2008 through 2026.  Various subsidiaries have state NOL carryforwards totaling approximately $168.0 million with expirations dates through the year 2027.

Effective January 1, 2007, we adopted FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes (“FIN 48”).  FIN 48 clarifies the accounting for uncertainty in income taxes recognized in financial statements. We had gross unrecognized tax benefits of $5.4 million as of December 31, 2007.  If recognized, $2.5 million would impact the effective tax rate.  As of March 31, 2008, there have been no material changes to our total amount of gross unrecognized tax benefits or to the total amount of unrecognized tax benefits that would impact the effective tax rate.  Unrecognized tax benefits are not expected to change significantly over the next twelve months.

We recognize accrued interest related to unrecognized tax benefits as a component of income tax expense.  Penalties, if incurred, would also be recognized as a component of income tax expense.  The amount of accrued interest expense related to unrecognized tax benefits was $1.2 million as of December 31, 2007.  As of March 31, 2008, there has been no material change to the amount of accrued interest expense related to unrecognized tax benefits.

We file numerous consolidated and separate state and local income tax returns in addition to our consolidated U.S. federal income tax return.  With few exceptions, we are no longer subject to U.S. federal, state or local income tax examinations for years before 2003.  These jurisdictions can, however, adjust NOL carryforwards from earlier years.

Although we believe we have adequately reserved for our uncertain tax positions, no assurance can be given that the final tax outcome of these matters will not be different.  We adjust these reserves in light of changing facts and circumstances and new information, such as the closing of a tax audit or the refinement of an estimate.  To the extent that the final tax outcome of these matters is different than the amounts recorded, such differences will impact the provision for income taxes in the period in which such determination is made.  The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate, as well as the related net interest.
 
(10)  Other Events
 
(a)  Litigation

 
16

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

 

We are a party to various legal actions and administrative proceedings and are subject to various claims arising in the ordinary course of our business, including claims that our services have resulted in injury or death to the residents of our centers, claims relating to employment and commercial matters. Although we intend to vigorously defend ourselves in these matters, there can be no assurance that the outcomes of these matters will not have a material adverse effect on our results of operations, financial condition and cash flows. In certain states in which we have or have had operations, insurance coverage for the risk of punitive damages arising from general and professional liability litigation may not be available due to state law public policy prohibitions. There can be no assurance that we will not be liable for punitive damages awarded in litigation arising in states for which punitive damage insurance coverage is not available.

We operate in industries that are extensively regulated. As such, in the ordinary course of business, we are continuously subject to state and federal regulatory scrutiny, supervision and control. Such regulatory scrutiny often includes inquiries, investigations, examinations, audits, site visits and surveys, some of which are non-routine. In addition to being subject to direct regulatory oversight of state and federal regulatory agencies, these industries are frequently subject to the regulatory supervision of fiscal intermediaries. If a provider is found by a court of competent jurisdiction to have engaged in improper practices, it could be subject to civil, administrative or criminal fines, penalties or restitutionary relief, and reimbursement authorities could also seek the suspension or exclusion of the provider or individual from participation in their program. We believe that there has been, and will continue to be, an increase in governmental investigations of long-term care providers, particularly in the area of Medicare/Medicaid false claims, as well as an increase in enforcement actions resulting from these investigations. Adverse determinations in legal proceedings or governmental investigations, whether currently asserted or arising in the future, could have a material adverse effect on our financial position, results of operations and cash flows.

In December 2006, Harborside was notified by the United States Department of Justice (“DOJ”) that one of its subsidiaries is one of a significant number of unrelated defendants in a qui tam lawsuit filed under the Federal False Claims Act. It is our understanding that Harborside’s involvement relates to its Medicare billings for durable medical equipment. Although the complaint remains under seal pending completion of the DOJ’s investigation, it is our understanding that neither Sun Healthcare Group, Inc. nor any of its other subsidiaries is a defendant in this litigation.  We have met with a representative of the DOJ to discuss the litigation and intend to continue to cooperate with the investigation and respond to the litigation in a timely fashion.  Based on our understanding of the allegations as described by the DOJ, we do not believe that the litigation will have a material impact on our operations, financial condition and cash flows.

The Kentucky Attorney General’s office has commenced an investigation that relates to potentially all of our 19 centers in Kentucky, which we acquired in April 2007 in the Harborside acquisition.  We became aware of this investigation after receipt of subpoenas by many of our centers for records of certain of our current and former residents for specified periods of time between 2005 and 2008.  We have not been informed of the precise nature of the investigation, although we are cooperating with the Attorney General’s office.

(b)  Other Inquiries

From time to time, fiscal intermediaries and Medicaid agencies examine cost reports filed by predecessor operators of our skilled nursing centers. If, as a result of any such examination, it is concluded that overpayments to a predecessor operator were made, we, as the current operator of such centers, may be held financially responsible for such overpayments. At this time we are unable to predict the outcome of any existing or future examinations.

(11)  Segment Information

We operate predominantly in the long-term care segment of the healthcare industry. We are a provider of long-term, sub-acute and related ancillary care services to nursing home patients.

The following summarizes the services provided by our reportable and other segments:
 
Inpatient Services:  This segment provides, among other services, inpatient skilled nursing and custodial services as well as rehabilitative, restorative and transitional medical services. We provide 24-hour nursing care in these centers by registered nurses, licensed practical nurses and certified nursing aids.  At March 31, 2008, we operated 213 long-term care centers (consisting of 190 skilled nursing centers, 15 assisted living and independent living centers and eight mental health centers)
 

 
17

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)

with 24,002 licensed beds as compared with 139 long-term care centers (consisting of 118 skilled nursing centers, 13 assisted living and independent living centers, seven mental health centers, and one specialty acute care hospital) with 15,198 licensed beds at March 31, 2007.

Rehabilitation Therapy Services:  This segment provides primarily physical, occupational and speech and respiratory therapy supplies and services to affiliated and nonaffiliated skilled nursing centers.  At March 31, 2008, this segment provided services in 32 states to 418 centers, of which 312 were nonaffiliated and 106 were affiliated, as compared to 390 centers, of which 303 were nonaffiliated and 87 were affiliated at March 31, 2007.

Medical Staffing Services: As of March 31, 2008, this segment provided services in 34 states and derived 62.3% of its revenues from hospitals and other providers, 21.6% from skilled nursing centers, 11.7% from schools and 4.4% from prisons. We provide (i) licensed therapists skilled in the areas of physical, occupational and speech therapy, (ii) nurses, (iii) pharmacists, pharmacist technicians and medical imaging technicians, (iv) physicians, and (v) related medical personnel. As of March 31, 2008, this segment had 29 branch offices which provided temporary therapy, nursing and physician staffing services in major metropolitan areas, one branch office which specialized in the placement of temporary traveling therapists, and one branch office which specialized in temporary pharmaceutical staffing.

Corporate assets primarily consist of cash and cash equivalents, receivables from subsidiary segments, notes receivable, property and equipment and unallocated intangible assets. Although corporate assets include unallocated intangible assets, the amortization, if applicable, is reflected in the results of operations of the associated segment.

The accounting policies of the segments are the same as those described in Note 3 – “Summary of Significant Accounting Policies” of our 2007 Form 10-K.  We primarily evaluate segment performance based on profit or loss from operations before reorganization and restructuring items, income taxes and extraordinary items. Gains or losses on sales of assets and certain items including impairment of assets recorded in connection with SFAS No. 144 and Statement of Financial Accounting Standard No. 142, Goodwill and Other Intangible Assets (“SFAS No. 142”), and restructuring costs are not considered in the evaluation of segment performance.  Interest expense is recorded in the segment carrying the obligation to which the interest relates.

Our reportable segments are strategic business units that provide different products and services. They are managed separately because each business has different marketing strategies due to differences in types of customers, distribution channels and capital resource needs.

 
18

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)


The following tables summarize, for the periods indicated, operating results and other financial information, by business segment:

As of and for the
                                         
Three Months Ended
                                         
March 31, 2008
             
Segment Information (in thousands):
             
                                           
         
Rehabilitation
   
Medical
                         
   
    Inpatient
   
Therapy
   
Staffing
         
Intersegment
         
Discontinued
 
   
    Services
   
Services
   
Services
   
Corporate
   
Eliminations
   
Consolidated
   
Operations
 
                                           
Revenues from external customers
$
406,853
 
$
21,710
 
$
29,668
 
$
11
 
$
-
 
$
458,242
 
$
16,454
 
                                           
Intersegment revenues
 
-
   
14,291
   
533
   
-
   
(14,824
)
 
-
   
-
 
                                           
Total revenues
 
406,853
   
36,001
   
30,201
   
11
   
(14,824
)
 
458,242
   
16,454
 
                                           
Operating salaries and benefits
 
206,338
   
29,926
   
22,473
   
-
   
-
   
258,737
   
5,776
 
                                           
Self-insurance for workers’
                                         
compensation and general and
                                         
professional liability insurance
 
14,218
   
527
   
342
   
115
   
-
   
15,202
   
311
 
                                           
Other operating costs
 
104,873
   
1,502
   
3,869
   
-
   
(14,824
)
 
95,420
   
8,686
 
                                           
General and administrative expenses
 
9,512
   
1,617
   
811
   
16,585
   
-
   
28,525
   
231
 
                                           
Provision (adjustment) for losses                                          
  on accounts receivable
 
2,942
   
89
   
332
   
-
   
-
   
3,363
   
(62
)
                                           
Segment operating income (loss)
$
68,970
 
$
2,340
 
$
2,374
 
$
(16,689
)
$
-
 
$
56,995
 
$
1,512
 
                                           
Center rent expense
 
18,470
   
86
   
248
   
-
   
-
   
18,804
   
1,209
 
                                           
Depreciation and amortization
 
8,701
   
126
   
195
   
687
   
-
   
9,709
   
7
 
                                           
Interest, net
 
3,318
   
-
   
(1
)
 
11,114
   
-
   
14,431
   
3
 
                                           
Net segment income (loss)
$
38,481
 
$
2,128
 
$
1,932
 
$
(28,490
)
$
-
 
$
14,051
 
$
293
 
                                           
Identifiable segment assets
$
1,109,916
 
$
14,307
 
$
37,875
 
$
732,891
 
$
(521,050
)
$
1,373,939
 
$
14,009
 
                                           
Goodwill
$
319,744
 
$
-
 
$
4,533
 
$
-
 
$
-
 
$
324,277
 
$
-
 
                                           
Segment capital expenditures
$
5,299
 
$
51
 
$
34
 
$
482
 
$
-
 
$
5,866
 
$
50
 

______________________________________
General and administrative expenses include operating administrative expenses.
 
The term “segment operating income (loss)” is defined as earnings before center rent expense, depreciation and amortization, interest, net gain (loss) on sale of assets, income tax expense and discontinued operations.
 
The term “net segment income (loss)” is defined as earnings, net gain (loss) on sale of assets, net, income tax expense and discontinued operations.


 
19

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)



As of and for the
                                         
Three Months Ended
                                         
March 31, 2007
             
Segment Information (in thousands):
             
                                           
         
Rehabilitation
   
Medical
                         
   
    Inpatient
   
Therapy
   
Staffing
         
Intersegment
         
Discontinued
 
   
    Services
   
Services
   
Services
   
Corporate
   
Eliminations
   
Consolidated
   
Operations
 
                                           
Revenues from external customers
$
218,142
 
$
20,680
 
$
23,747
 
$
7
 
$
-
 
$
262,576
 
$
22,066
 
                                           
Intersegment revenues
 
-
   
10,262
   
187
   
-
   
(10,449
)
 
-
   
-
 
                                           
Total revenues
 
218,142
   
30,942
   
23,934
   
7
   
(10,449
)
 
262,576
   
22,066
 
                                           
Operating salaries and benefits
 
107,327
   
26,048
   
18,900
   
-
   
-
   
152,275
   
8,786
 
                                           
Self-insurance for workers’
                                         
compensation and general and
                                         
professional liability insurance
 
9,511
   
397
   
294
   
87
   
-
   
10,289
   
546
 
                                           
Other operating costs
 
59,053
   
1,717
   
1,806
   
18
   
(10,449
)
 
52,145
   
10,442
 
                                           
General and administrative expenses
 
5,306
   
1,257
   
1,026
   
12,834
   
-
   
20,423
   
55
 
                                           
Provision (adjustment) for losses                                          
   on accounts receivable
 
2,116
   
(80
)
 
112
   
-
   
-
   
2,148
   
375
 
                                           
Segment operating income (loss)
$
34,829
 
$
1,603
 
$
1,796
 
$
(12,932
)
$
-
 
$
25,296
 
$
1,862
 
                                           
Center rent expense
 
13,180
   
50
   
199
   
-
   
-
   
13,429
   
1,069
 
                                           
Depreciation and amortization
 
3,155
   
116
   
169
   
436
   
-
   
3,876
   
79
 
                                           
Interest, net
 
2,483
   
10
   
15
   
(446
)
 
-
   
2,062
   
38
 
                                           
Net segment income (loss)
$
16,011
 
$
1,427
 
$
1,413
 
$
(12,922
)
$
-
 
$
5,929
 
$
676
 
                                           
Identifiable segment assets
$
372,176
 
$
13,211
 
$
34,632
 
$
675,884
 
$
(521,053
)
$
574,850
 
$
14,812
 
                                           
Goodwill
$
50,045
 
$
-
 
$
4,560
 
$
-
 
$
-
 
$
54,605
 
$
-
 
                                           
Segment capital expenditures
$
5,890
 
$
796
 
$
97
 
$
407
 
$
-
 
$
7,190
 
$
60
 

______________________________________
General and administrative expenses include operating administrative expenses.
 
The term “segment operating income (loss)” is defined as earnings before center rent expense, depreciation and amortization, interest, net gain (loss) on sale of assets, income tax expense and discontinued operations.
 
The term “net segment income (loss)” is defined as earnings, net gain (loss) on sale of assets, net, income tax expense and discontinued operations.


 
20

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)


Measurement of Segment Income

We evaluate financial performance and allocate resources primarily based on income or loss from operations before income taxes, excluding any unusual items. The following table reconciles net segment income to consolidated income before income taxes and discontinued operations for the three months ended March 31 (in thousands):

   
2008
   
2007
 
             
Net segment income
$
14,051
 
$
5,929
 
Gain (loss) on sale of assets
 
77
   
(8
)
Consolidated income before income taxes
           
and discontinued operations
$
14,128
 
$
5,921
 

(12) Summarized Consolidating Information

In connection with the Company’s offering of the Notes in April 2007, certain of our subsidiaries (the “Guarantors”) have, jointly and severally, unconditionally guaranteed the Notes. These guarantees are subordinated to all existing and future senior debt and guarantees of the Guarantors and are unsecured.

We conduct all of our business through and derive virtually all of our income from our subsidiaries. Therefore, our ability to make required payments with respect to indebtedness (including the Notes) and other obligations depends on the financial results and condition of our subsidiaries and our ability to receive funds from our subsidiaries.

Pursuant to Rule 3-10 of Regulation S-X, the following summarized consolidating information is for the Company (the “Parent”), the 100% owned Guarantors, and the Parent’s non-Guarantor subsidiaries with respect to the Notes. This summarized financial information has been prepared from the books and records maintained by the Parent, the Guarantors and the non-Guarantor subsidiaries. The summarized financial information may not necessarily be indicative of the results of operations or financial position had the Guarantors or non-Guarantor subsidiaries operated as independent entities. The separate financial statements of the Guarantors are not presented because management has determined they would not be material to investors. In addition, intercompany activities between subsidiaries and the Parent are presented within operating activities on the condensed consolidating statement of cash flows.

Condensed consolidating financial statements for the Company and its subsidiaries, including the Parent only, the combined Guarantor Subsidiaries and the combined Non-Guarantor Subsidiaries are as follows:



 
21

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)


CONDENSED CONSOLIDATING BALANCE SHEETS

As of March 31, 2008
(in thousands)
 

         
Combined
   
Combined
             
   
Parent
   
Guarantor
   
Non-Guarantor
             
   
Company
   
Subsidiaries
   
Subsidiaries
   
Elimination
   
Consolidated
 
                               
Current assets:
                             
Cash and cash equivalents
$
42,797
 
$
18,457
 
$
1,628
 
$
-
 
$
62,882
 
Restricted cash
 
27,176
   
6,826
   
3,924
   
-
   
37,926
 
Accounts receivable, net
 
-
   
198,696
   
2,395
   
(9
)
 
201,082
 
Other receivables, net
 
14
   
1,405
   
-
   
(163
)
 
1,256
 
Prepaid expenses and other assets
 
6,433
   
9,712
   
583
   
(522
)
 
16,206
 
Assets held for sale
 
930
   
9,786
   
11
   
-
   
10,727
 
Deferred tax assets
 
-
   
37,188
   
1,296
   
(1,905
)
 
36,579
 
Total current assets
 
77,350
   
282,070
   
9,837
   
(2,599
)
 
366,658
 
Property and equipment, net
 
8,718
   
504,864
   
69,508
   
-
   
583,090
 
Intangible assets, net
 
40,457
   
13,640
   
1,250
   
-
   
55,347
 
Goodwill
 
-
   
324,277
   
-
   
-
   
324,277
 
Restricted cash, non-current
 
-
   
3,263
   
-
   
-
   
3,263
 
Deferred tax assets
 
6,171
   
56,413
   
-
   
(13,746
)
 
48,838
 
Other assets
 
1,486
   
4,953
   
5,526
   
(5,490
)
 
6,475
 
Intercompany balances
 
505,591
   
-
   
13,112
   
(518,703
)
 
-
 
Investment in subsidiaries
 
275,530
   
-
   
-
   
(275,530
)
 
-
 
Total assets
$
915,303
 
$
1,189,480
 
$
99,233
 
$
(816,068
)
$
1,387,948
 
                               
Current liabilities:
                             
Accounts payable
$
14,571
 
$
36,174
 
$
510
 
$
(9
)
$
51,246
 
Accrued compensation and benefits  
 
7,562
   
54,738
   
770
   
-
   
63,070
 
Accrued self-insurance obligations, current portion
 
3,798
   
44,907
   
2,660
   
-
   
51,365
 
Income taxes payable
 
3,480
   
-
   
-
   
-
   
3,480
 
Liabilities held for sale
 
-
   
3,411
   
-
   
-
   
3,411
 
Other accrued liabilities
 
21,041
   
37,608
   
6,014
   
(163
)
 
64,500
 
    Current portion of long-term debt and capital lease
       obligations
 
3,711
   
26,944
   
1,169
   
-
   
31,824
 
        Deferred tax liabilities 
 
1,905
   
-
   
-
   
(1,905
)
 
-
 
Total current liabilities
 
56,068
   
203,782
   
11,123
   
(2,077
)
 
268,896
 
Accrued self-insurance obligations, net of current portion
 
35,647
   
69,690
   
429
   
-
   
105,766
 
Long-term debt and capital lease obligations, net of current
   portion
 
545,860
   
83,284
   
65,312
   
-
   
694,456
 
Unfavorable lease obligations, net
 
-
   
23,638
   
-
   
(5,490
)
 
18,148
 
Deferred tax liabilities
 
-
   
-
   
13,746
   
(13,746
)
 
-
 
Intercompany balances
 
-
   
518,703
   
-
   
(518,703
)
 
-
 
Other long-term liabilities
 
23,348
   
17,106
   
5,271
   
-
   
45,725
 
Total liabilities
 
660,923
   
916,203
   
95,881
   
(540,016
)
 
1,132,991
 
                               
Minority interest
 
-
   
1,099
   
-
   
(522
)
 
577
 
                               
Stockholders’ equity:
                             
Common stock
 
430
   
-
   
-
   
-
   
430
 
Additional paid-in capital
 
601,467
   
-
   
-
   
-
   
601,467
 
Accumulated deficit
 
(343,393
)
 
272,178
   
3,352
   
(275,530
)
 
(343,393
)
Accumulated other comprehensive loss, net
 
(4,124
)
 
-
   
-
   
-
   
(4,124
)
Total stockholders’ equity
 
254,380
   
272,178
   
3,352
   
(275,530
)
 
254,380
 
Total liabilities and stockholders’ equity
$
915,303
 
$
1,189,480
 
$
99,233
 
$
(816,068
)
$
1,387,948
 

 
22

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)


CONDENSED CONSOLIDATING BALANCE SHEETS

As of  December 31, 2007
(in thousands)

         
Combined
   
Combined
             
   
Parent
   
Guarantor
   
Non-Guarantor
             
   
Company
   
Subsidiaries
   
Subsidiaries
   
Elimination
   
Consolidated
 
                               
Current assets:
                             
Cash and cash equivalents
$
30,221
 
$
23,547
 
$
2,064
 
$
-
 
$
55,832
 
Restricted cash
 
27,441
   
6,370
   
3,554
   
-
   
37,365
 
Accounts receivable, net
 
-
   
187,144
   
1,747
   
(9
)
 
188,882
 
Other receivables, net
 
21
   
1,667
   
(53
)
 
-
   
1,635
 
Prepaid expenses and other assets
 
2,039
   
9,463
   
153
   
-
   
11,655
 
Assets held for sale
 
912
   
9,015
   
(3
)
 
-
   
9,924
 
Deferred tax assets
 
35,344
   
-
   
10
   
-
   
35,354
 
Total current assets
 
95,978
   
237,206
   
7,472
   
(9
)
 
340,647
 
Property and equipment, net
 
8,924
   
507,022
   
70,026
   
-
   
585,972
 
Intangible assets, net
 
41,612
   
14,142
   
1,290
   
-
   
57,044
 
Goodwill
 
-
   
324,277
   
-
   
-
   
324,277
 
Restricted cash, non-current
 
566
   
3,263
   
-
   
-
   
3,829
 
Deferred tax assets
 
51,933
   
-
   
(101
)
 
-
   
51,892
 
Other assets
 
5,190
   
4,939
   
36
   
-
   
10,165
 
Investment in subsidiaries
 
249,903
   
-
   
-
   
(249,903
)
 
-
 
Total assets
$
454,166
 
$
1,090,849
 
$
78,723
 
$
(249,912
)
$
1,373,826
 
                               
Current liabilities:
                             
Accounts payable
$
14,203
 
$
38,095
 
$
547
 
$
(9
)
$
52,836
 
Accrued compensation and benefits
 
8,100
   
53,270
   
586
   
-
   
61,956
 
Accrued self-insurance obligations, current portion
 
5,509
   
39,822
   
3,315
   
-
   
48,646
 
Income taxes payable
 
3,000
   
-
   
-
   
-
   
3,000
 
Liabilities held for sale
 
-
   
3,181
   
-
   
-
   
3,181
 
Other accrued liabilities
 
15,063
   
36,667
   
6,272
   
-
   
58,002
 
Current portion of long-term debt and capital lease obligations
 
3,760
   
24,397
   
1,148
   
-
   
29,305
 
Total current liabilities
 
49,635
   
195,432
   
11,868
   
(9
)
 
256,926
 
Accrued self-insurance obligations, net of current portion
 
36,415
   
69,690
   
429
   
-
   
106,534
 
Long-term debt and capital lease obligations, net of current portion
 
546,739
   
87,606
   
65,618
   
-
   
699,963
 
Unfavorable lease obligations, net
 
-
   
24,949
   
(5,989
)
 
-
   
18,960
 
Intercompany balances
 
(444,757
)
 
448,544
   
(3,787
)
 
-
   
-
 
Other long-term liabilities
 
18,986
   
18,064
   
7,667
   
-
   
44,717
 
Total liabilities
 
207,018
   
844,285
   
75,806
   
(9
)
 
1,127,100
 
                               
Minority interest
 
892
   
100
   
(522
)
 
-
   
470
 
                               
Stockholders’ equity:
                             
Common stock
 
430
   
-
   
-
   
-
   
430
 
Additional paid-in capital
 
600,199
   
-
   
-
   
-
   
600,199
 
Accumulated deficit
 
(351,970
)
 
246,464
   
3,439
   
(249,903
)
 
(351,970
)
Accumulated other comprehensive loss, net
 
(2,403
)
 
-
   
-
   
-
   
(2,403
)
Total stockholders’ equity
 
246,256
   
246,464
   
3,439
   
(249,903
)
 
246,256
 
Total liabilities and stockholders’ equity
$
454,166
 
$
1,090,849
 
$
78,723
 
$
(249,912
)
$
1,373,826
 


 
23

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)


CONDENSED CONSOLIDATING INCOME STATEMENTS

For the Three Months Ended March 31, 2008
(in thousands)

         
Combined
   
Combined
             
   
Parent
   
Guarantor
   
Non-Guarantor
             
   
Company
   
Subsidiaries
   
Subsidiaries
   
Elimination
   
Consolidated
 
                               
Total net revenues
$
12
 
$
467,411
 
$
5,643
 
$
(14,824
)
$
458,242
 
Costs and expenses:
                             
Operating salaries and benefits
 
1
   
255,678
   
3,058
   
-
   
258,737
 
Self-insurance for workers’ compensation and
                             
general and professional liability insurance
 
115
   
14,927
   
160
   
-
   
15,202
 
General and administrative expenses (1)
 
16,586
   
11,939
   
-
   
-
   
28,525
 
Other operating costs
 
-
   
109,041
   
1,203
   
(14,824
)
 
95,420
 
Center rent expense
 
-
   
19,375
   
(571
)
 
-
   
18,804
 
Depreciation and amortization
 
687
   
8,462
   
560
   
-
   
9,709
 
Provision for losses on accounts receivable
 
-
   
3,244
   
119
   
-
   
3,363
 
Interest, net
 
11,113
   
2,154
   
1,164
   
-
   
14,431
 
Gain on sale of assets
 
(77
)
 
-
   
-
   
-
   
(77
)
Income from investment in subsidiaries
 
(25,627
)
 
-
   
-
   
25,627
   
-
 
Total costs and expenses
 
2,798
   
424,820
   
5,693
   
10,803
   
444,114
 
                               
Income (loss) before income taxes and
                             
discontinued operations
 
(2,786
)
 
42,591
   
(50
)
 
(25,627
)
 
14,128
 
Income tax (benefit) expense
 
(11,362
)
 
17,036
   
(20
)
 
-
 
 
5,654
 
Income (loss) from continuing operations
 
8,576
 
 
25,555
   
(30
)
 
(25,627
)
 
8,474
 
                               
Discontinued operations:
                             
Income from discontinued operations, net
 
1
   
163
   
1
   
-
   
165
 
(Loss) gain on disposal of discontinued
                             
operations, net
 
-
   
(4
)
 
(58
)
 
-
   
(62
)
Income (loss) on discontinued operations, net
 
1
   
159
   
(57
)
 
-
   
103
 
                               
Net income (loss)
$
8,577
 
$
25,714
 
$
(87
)
$
(25,627
)
$
8,577
 

(1) Includes operating administrative expenses

 
24

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)


CONDENSED CONSOLIDATING INCOME STATEMENTS

For the Three Months Ended March 31, 2007
(in thousands)

         
Combined
   
Combined
             
   
Parent
   
Guarantor
   
Non-Guarantor
             
   
Company
   
Subsidiaries
   
Subsidiaries
   
Elimination
   
Consolidated
 
                               
Total net revenues
$
8
 
$
270,942
 
$
2,075
 
$
(10,449
)
$
262,576
 
Costs and expenses:
                             
Operating salaries and benefits
 
-
   
151,159
   
1,116
   
-
   
152,275
 
Self-insurance for workers’ compensation and
                             
general and professional liability insurance
 
87
   
10,106
   
96
   
-
   
10,289
 
General and administrative expenses (1)
 
13,097
   
7,322
   
4
   
-
   
20,423
 
Other operating costs
 
-
   
62,213
   
381
   
(10,449
)
 
52,145
 
Center rent expense
 
-
   
13,854
   
(425
)
 
-
   
13,429
 
Depreciation and amortization
 
436
   
2,987
   
453
   
-
   
3,876
 
Provision for losses on accounts receivable
 
-
   
2,143
   
5
   
-
   
2,148
 
Interest, net
 
(617
)
 
1,906
   
773
   
-
   
2,062
 
Loss on sale of assets
 
-
   
8
   
-
   
-
   
8
 
Income from investment in subsidiaries
 
(18,916
)
 
-
   
-
   
18,916
   
-
 
Total costs and expenses
 
(5,913
)
 
251,698
   
2,403
   
8,467
   
256,655
 
                               
Income (loss) before income taxes and
                             
discontinued operations
 
5,921
   
19,244
   
(328
)
 
(18,916
)
 
5,921
 
Income tax expense
 
2,368
   
-
   
-
   
-
   
2,368
 
(Loss) income from continuing operations
 
3,553
   
19,244
   
(328
)
 
(18,916
)
 
3,553
 
                               
Discontinued operations:
                             
Income from discontinued operations, net
 
720
   
696
   
24
   
(720
)
 
720
 
(Loss) gain on disposal of discontinued
                             
operations, net
 
(350
)
 
(555
)
 
205
   
350
   
(350
)
Income (loss) on discontinued operations, net
 
370
   
141
   
229
   
(370
)
 
370
 
                               
Net income (loss)
$
3,923
 
$
19,385
 
$
(99
)
$
(19,286
)
$
3,923
 

(1)   Includes operating administrative expenses

 
25

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

(UNAUDITED)



CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

For the Three Months Ended March 31, 2008
(in thousands)

         
Combined
   
Combined
             
   
Parent
   
Guarantor
   
Non-Guarantor
             
   
Company
   
Subsidiaries
   
Subsidiaries
   
Elimination
   
Consolidated
 
                               
Net cash provided by operating activities
$
10,167
 
$
2,519
 
$
78
 
$
-
 
$
12,764
 
                               
Cash flows from investing activities:
                             
Capital expenditures
 
(481
)
 
(5,429
)
 
(6
)
 
-
   
(5,916
)
Proceeds from sale of assets held for sale
 
3,777
   
-
   
-
   
-
   
3,777
 
Acquisitions
 
-
   
(307
)
 
-
   
-
   
(307
)
Net cash provided by (used for) investing activities
 
3,296
   
(5,736
)
 
(6
)
 
-
   
(2,446
)
                               
Cash flows from financing activities:
                             
Long-term debt repayments
 
(874
)
 
(1,661
)
 
(285
)
 
-
   
(2,820
)
Principal payments under capital lease 
        obligations
 
(52
)
 
(212
)
 
-
   
-
   
(264
)
Proceeds from issuance of common stock
 
39
   
-
   
-
   
-
   
39
 
Distribution of partnership equity
 
-
   
-
   
(223
)
 
-
   
(223
)
Net cash used for financing activities
 
(887
)
 
(1,873
)
 
(508
)
 
-
   
(3,268
)
Net increase (decrease) in cash and cash equivalents
 
12,576
   
(5,090
)
 
(436
)
 
-
   
7,050
 
Cash and cash equivalents at beginning of period
 
30,221
   
23,547
   
2,064
   
-
   
55,832
 
Cash and cash equivalents at end of period
$
42,797
 
$
18,457
 
$
1,628
 
$
-
 
$
62,882
 
 

For the Three Months Ended March 31, 2007
(in thousands)

         
Combined
   
Combined
             
   
Parent
   
Guarantor
   
Non-Guarantor
             
   
Company
   
Subsidiaries
   
Subsidiaries
   
Elimination
   
Consolidated
 
                               
Net cash (used for) provided by operating activities
$
(27,802
)
$
27,880
 
$
1,493
 
$
-
 
$
1,571
 
                               
Cash flows from investing activities:
                             
Capital expenditures
 
(399
)
 
(6,473
)
 
(378
)
 
-
   
(7,250
)
Proceeds from assets held for sale
 
-
   
3,238
   
-
   
-
   
3,238
 
Net cash used for investing activities
 
(399
)
 
(3,235
)
 
(378
)
 
-
   
(4,012
)
                               
Cash flows from financing activities:
                             
Net borrowings under Credit Agreement
 
6
   
-
   
-
   
-
   
6
 
Long-term debt repayments
 
(3,177
)
 
(26,111
)
 
(319
)
 
-
   
(29,607
)
Principal payments under capital lease
       obligations
 
(46
)
 
(462
)
 
(32
)
 
-
   
(540
)
Proceeds from issuance of common stock
 
573
   
-
   
-
   
-
   
573
 
Distribution of partnership equity
 
-
   
-
   
(256
)
 
-
   
(256
)
Net cash used for financing activities
 
(2,644
)
 
(26,573
)
 
(607
)
 
-
   
(29,824
)
Net (decrease) increase in cash and cash equivalents
 
(30,845
)
 
(1,928
)
 
508
   
-
   
(32,265
)
Cash and cash equivalents at beginning of period
 
119,810
   
11,337
   
788
   
-
   
131,935
 
Cash and cash equivalents at end of period
$
88,965
 
$
9,409
 
$
1,296
 
$
-
 
$
99,670
 


 
26

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

ITEM 2.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Overview

Sun Healthcare Group, Inc.’s subsidiaries are providers of long-term, subacute and related specialty healthcare services primarily to the senior population in the United States. Our core business is providing inpatient services, primarily through 213 skilled nursing centers, 15 assisted and independent living centers and eight mental health centers with 24,002 licensed beds located in 25 states as of March 31, 2008. Our subsidiaries also provide hospice services, rehabilitation therapy services and temporary medical staffing services to skilled nursing centers.

Revenues from Medicare, Medicaid and Other Sources

We receive revenues from Medicare, Medicaid, commercial insurance, self-pay residents, other third party payors and long-term care centers that utilize our specialty medical services. The sources and amounts of our inpatient services revenues are determined by a number of factors, including the number of licensed beds and occupancy rates of our centers, the acuity level of patients and the rates of reimbursement among payors. Federal and state governments continue to focus on methods to curb spending on health care programs such as Medicare and Medicaid. This focus has not been limited to skilled nursing centers, but includes other services provided by us, such as skilled therapy services. We cannot at this time predict the extent to which proposals limiting federal or state expenditures will be adopted or, if adopted and implemented, what effect, if any, such proposals will have on us. Efforts to impose reduced coverage, greater discounts and more stringent cost controls by government and other payors are expected to continue.

The following table sets forth the total nonaffiliated revenues and percentage of revenues by payor source for our continuing operations, on a consolidated and on an inpatient operations only basis, for the periods indicated (data includes revenues for acquired centers following the date of acquisition only):

   
For the Three Months Ended
 
Sources of Revenues
 
March 31, 2008
   
March 31, 2007
 
   
(dollars in thousands)
 
Consolidated:
                   
  Medicaid
$
182,623
 
39.9
%
$
101,650
 
38.7
%
  Medicare
 
131,639
 
28.7
   
67,189
 
25.6
 
  Private pay and other
 
143,980
 
31.4
   
93,737
 
35.7
 
     Total
$
458,242
 
100.0
%
$
262,576
 
100.0
%

Inpatient Only:
                   
  Medicaid
$
182,605
 
44.9
%
$
101,623
 
46.6
%
  Medicare
 
128,894
 
31.7
   
65,412
 
30.0
 
  Private pay and other
 
95,354
 
23.4
   
51,107
 
23.4
 
     Total
$
406,853
 
100.0
%
$
218,142
 
100.0
%

Medicare

Medicare is available to nearly every United States citizen 65 years of age and older. It is a broad program of health insurance designed to help the nation’s elderly meet hospital, hospice, home health and other health care costs. Health insurance coverage extends to certain persons under age 65 who qualify as disabled or those having end-stage renal disease. Medicare is comprised of four related health insurance programs.  Medicare Part A provides for inpatient services including hospital, skilled long-term care, and home healthcare.  Medicare Part B provides for outpatient services including physicians’ services, diagnostic service, durable medical equipment, skilled therapy services and medical supplies.  Medicare Part C is a managed care option (“Medicare Advantage”) for beneficiaries who are entitled to Part A and enrolled in Part B.  Medicare Part D is a benefit that provides prescription drug benefits for both Medicare and Medicare/Medicaid dually eligible patients.

Medicare reimburses our skilled nursing centers for Medicare Part A services under the Prospective Payment System (“PPS”) as defined by the Balanced Budget Act of 1997 and subsequently refined in 1999, 2000 and 2005.  PPS regulations predetermine a payment amount per patient, per day, based on the 1995 costs of treating patients indexed forward. The amount

 
27

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
to be paid is determined by classifying each patient into one of 53 resource utilization group (“RUG”) categories that are based upon each patient’s acuity level.

The following table sets forth the average amounts of inpatient Medicare Part A revenues per patient, per day, recorded by our long-term care (“LTC”) centers for the periods indicated (data includes revenues for acquired centers following the date of acquisition only):

 
For the Three Months Ended
 
 
March 31, 2008
   
March 31, 2007
 
$
411.37
 
$
365.70
 

The Centers for Medicare and Medicaid Services of the Department of Health and Human Services issued a final rule which includes a 3.3% market basket increase effective for the 2008 federal fiscal year which commenced on October 1, 2007.  We estimate that the implementation of this market basket increase has increased our revenues by approximately $3.5 million per quarter.

The Balanced Budget Act of 1997 established limits on reimbursement provided under Medicare Part B for therapy services.  An automatic exception is currently in place for LTC patients until at least July 1, 2008. In the event that Congress does not extend the exception process, we do not anticipate a material impact on our earnings.

Medicaid

Medicaid is a state-administered program financed by state funds and federal matching funds. The program provides for medical assistance to the indigent and certain other eligible persons. Although administered under broad federal regulations, states are given flexibility to construct programs and payment methods. Each state in which we operate nursing centers has its own unique Medicaid reimbursement program.  State Medicaid programs include systems that will reimburse a nursing center for reasonable costs it incurs in providing care to its patients, based upon cost from a prior base year, adjusted for inflation and per diems based upon patient acuity.

The following table sets forth the average amounts of inpatient Medicaid revenues per patient, per day (excluding any impact of state-imposed provider taxes), recorded by our LTC centers for the periods indicated (data includes revenues for acquired centers following the date of acquisition only):

 
For the Three Months Ended
 
 
March 31, 2008
   
March 31, 2007
 
$
165.90
 
$
148.53
 

Medicaid outlays are a significant component of state budgets, and there have been increased cost containment pressures on Medicaid outlays for nursing homes. It is not certain whether reductions in Medicaid rates would be imposed in the future for any states in which we operate.

Eighteen of the states in which we operate impose a provider tax on nursing homes as a method of increasing federal matching funds paid to those states for Medicaid.  Those states that have imposed the provider tax have used some or all of the matching funds to fund Medicaid reimbursement to nursing homes.

Private Payors

During the three months ended March 31, 2008, we received 31.4% of our revenues from commercial insurance, long-term care centers that utilize our specialty medical services, self-pay center residents, and other third party payors. These private third party payors are continuing their efforts to control healthcare costs through direct contracts with healthcare providers, increased utilization review and greater enrollment in managed care programs and preferred provider organizations. These private payors increasingly are demanding discounted fee structures and the assumption by healthcare providers of all or a portion of the financial risk.

 
28

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

Other Reimbursement Matters

Net revenues realizable under third-party payor agreements are subject to change due to examination and retroactive adjustment by payors during the settlement process. Under cost-based reimbursement plans, payors may disallow, in whole or in part, requests for reimbursement based on determinations that certain costs are not reimbursable or reasonable or because additional supporting documentation is necessary. We recognize revenues from third-party payors and accrue estimated settlement amounts in the period in which the related services are provided. We estimate these settlement balances by making determinations based on our prior settlement experience and our understanding of the applicable reimbursement rules and regulations.

Critical Accounting Policies Update

In October 2006, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards No. 157, Fair Value Measurements (“SFAS No. 157”), which effectively defines fair value for purposes of accounting principles generally accepted in the United States and expands disclosures of fair value measurements.  SFAS No. 157 changes the underlying methodology of establishing fair value for our financial instruments, including our interest rate swap agreement (see Note 3 – “Loan Agreements” and Note 5 – “Fair Value of Financial Instruments”).  There was no material impact on our financial condition upon adoption of SFAS No. 157 for our financial assets and financial liabilities.

We believe there have been no significant changes, other than the adoption of SFAS No. 157, during the three months ended March 31, 2008 to the items that we disclosed as our critical accounting policies and estimates in our discussion and analysis of financial condition and results of operations in our Annual Report on Form 10-K for the year ended December 31, 2007.

In March 2008, the FASB issued Statement of Financial Accounting Standards No. 161, Disclosures About Derivative Instruments and Hedging Activities – an amendment of FASB Statement No. 133 (“SFAS No. 161”), which expands quarterly disclosure requirements in Statement of Financial Accounting Standards No. 133 Accounting for Derivative Instruments and Hedging Activity (“SFAS No. 133”),  about an entity’s derivative instruments and hedging activities. SFAS No. 161 is effective for fiscal years beginning after November 15, 2008.  We are currently assessing the impact of SFAS No. 161 on our consolidated financial position and results of operations.


 
29

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

Results of Operations

The following table sets forth our historical consolidated income statements and certain percentage relationships for the three months ended March 31 (dollars in thousands):

               
As a Percentage of Net Revenues
 
                         
   
2008
   
2007
   
2008
   
2007
 
   
(unaudited)
   
(unaudited)
             
                         
Total net revenues
  $ 458,242     $ 262,576       100.0 %     100.0 %
Costs and expenses:
                               
Operating salaries and benefits
    258,737       152,275       56.6       57.9  
Self-insurance for workers’ compensation and general
                               
and professional liabilities
    15,202       10,289       3.3       3.9  
General and administrative expenses
    16,586       12,832       3.6       4.9  
Other operating costs
    107,359       59,736       23.4       22.8  
Center rent expense
    18,804       13,429       4.1       5.1  
Depreciation and amortization
    9,709       3,876       2.1       1.5  
Provision for losses on accounts receivable
    3,363       2,148       0.7       0.8  
Interest, net
    14,431       2,062       3.1       0.8  
Other (income) expenses
    (77 )     8       -       -  
Income before income taxes and discontinued
                               
operations
    14,128       5,921       3.1       2.3  
Income tax expense     5,654       2,368       1.2       0.9  
Income from continuing operations
    8,474       3,553       1.9       1.4  
Income from discontinued operations, net
    103       370       -       0.1  
Net income
  $ 8,577     $ 3,923       1.9 %     1.5 %

The following discussion of the “Three Months Ended March 31, 2008 Compared to Three Months Ended March 31, 2007” is based, in part, on the financial information presented in Note 11 – “Segment Information” in our consolidated financial statements.

Three Months Ended March 31, 2008 Compared to Three Months Ended March 31, 2007

The following summarizes our results of operations on a consolidated basis.  A more detailed discussion and analysis of the results of operations of each of our segments (Inpatient Services, Rehabilitation Therapy Services and Medical Staffing Services) is provided below under “Segment Information.”

Net revenue increased $195.6 million, or 74.5%, to $458.2 million for the three months ended March 31, 2008 from $262.6 million for the three months ended March 31, 2007. We reported net income for the three months ended March 31, 2008 of $8.6 million compared to net income of $3.9 million for the three months ended March 31, 2007.

The increase in net revenue for the 2008 period included $188.8 million of additional revenue in our Inpatient Services segment, of which $169.3 million is attributable to our acquisition of Harborside Healthcare Corporation (“Harborside”) in April 2007, with the remainder due to increases in Medicare Part A, Medicaid, private payor rates, and commercial insurance revenues, offset by decreases due to a lower Medicaid customer base.  The remainder of the increase primarily resulted from $6.3 million of revenue from our Medical Staffing segment mainly due to an increase in billable hours, increases in average bill rates, and the addition of a medical staffing business in the Harborside acquisition, and $5.1 million of revenue from our Rehabilitation Therapy segment due to the renegotiation of customer contracts and an increase in service volume.

Operating salaries and benefits, excluding workers’ compensation insurance costs, increased $106.4 million, or 69.9%, to $258.7 million (56.6% of net revenues) for the three months ended March 31, 2008 from $152.3 million (57.9% of net revenues) for the three months ended March 31, 2007.  The addition of Harborside contributed $91.6 million to the increases while the remaining increase resulted primarily from $6.7 million of wage increases in our Inpatient Services segment, a

 
30

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
$3.6 million increase from our Medical Staffing segment, and a $3.9 million increase from our Rehabilitation Therapy segment, the latter two segments’ increases being directly attributable to business growth.

Self-insurance for workers’ compensation and general and professional liability insurance increased $4.9 million, or 47.6%, to $15.2 million (3.3% of net revenues) for the three months ended March 31, 2008 from $10.3 million (3.9% of net revenues) for the three months ended March 31, 2007.  The addition of Harborside contributed $4.7 million to the increase, which was partially offset by reduced general liability insurance claims.

Other operating costs increased $47.7 million, or 79.9%, to $107.4 million (23.4% of net revenues) for the three months ended March 31, 2008 from $59.7 million (22.8% of net revenues) for the three months ended March 31, 2007.  The increase was primarily due to $40.3 million in additional costs due to the addition of Harborside’s operations and a $5.5 million increase in our Inpatient Services segment driven by increased therapy costs due to an increase in higher acuity patients requiring more rehabilitation therapy, as well as a $2.1 million increase in travel and lodging expenses in our Medical Staffing segment.

Center rent expense increased $5.4 million, or 40.3%, to $18.8 million (4.1% of net revenues) for the three months ended March 31, 2008 from $13.4 million (22.8% of net revenues) for the three months ended March 31, 2007, of which $4.7 million was due to the additional rent expense resulting from the Harborside acquisition.

General and administrative expenses increased $3.8 million, or 29.7%, to $16.6 million (3.6% of net revenues) for the three months ended March 31, 2008 from $12.8 million (4.9% of net revenues) for the three months ended March 31, 2007.  The increase was primarily due to costs incurred for various process improvements and other initiatives.

Depreciation and amortization increased $5.8 million, or 148.7%, to $9.7 million (2.1% of net revenues) for the three months ended March 31, 2008 from $3.9 million (1.5% of net revenues) for the three months ended March 31, 2007.  Substantially all of the increase was attributable to the addition of the Harborside centers.

The provision for losses on accounts receivable increased $1.3 million, or 61.9%, to $3.4 million (0.7% of net revenues) for the three months ended March 31, 2008 from $2.1 million (0.8% of net revenues) for the three months ended March 31, 2007.  The increase was due to the addition of Harborside’s operations.

Net interest expense increased $12.3 million, or 585.7%, to $14.4 million (3.1% of net revenues) for the three months ended March 31, 2008 from $2.1 million (0.8% of net revenues) for the three months ended March 31, 2007. The increase was attributable to the debt incurred and assumed in the Harborside acquisition.

Segment Information

The following table sets forth the amount and percentage of certain elements of total net revenues for the three months ended March 31 (dollars in thousands):

   
2008
   
2007
 
                         
Inpatient Services
$
406,853
   
88.7
%
$
218,142
   
83.1
%
Rehabilitation Therapy Services
 
36,001
   
7.9
   
30,942
   
11.8
 
Medical Staffing Services
 
30,201
   
6.6
   
23,934
   
9.1
 
Corporate
 
11
   
-
   
7
   
-
 
Intersegment Eliminations
 
(14,824
)
 
(3.2
)
 
(10,449
)
 
(4.0
)
                         
Total net revenues
$
458,242
   
100.0
%
$
262,576
   
100.0
%


 
31

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

Inpatient services revenues for long-term care, subacute care and assisted living services include revenues billed to patients for therapy and medical staffing provided by our affiliated operations.  The following table sets forth a summary of the intersegment revenues for the three months ended March 31 (in thousands):

   
2008
   
2007
 
             
Inpatient Services
$
-
 
$
-
 
Rehabilitation Therapy Services
 
14,291
   
10,262
 
Medical Staffing Services
 
533
   
187
 
Total intersegment revenue
$
14,824
 
$
10,449
 

The following table sets forth the amount of net segment income (loss) for the three months ended March 31 (in thousands):

   
2008
   
2007
 
             
Inpatient Services
$
38,481
 
$
16,011
 
Rehabilitation Therapy Services
 
2,128
   
1,427
 
Medical Staffing Services
 
1,932
   
1,413
 
Net segment income before Corporate
 
42,541
   
18,851
 
Corporate
 
(28,490
)
 
(12,922
)
Net segment income
$
14,051
 
$
5,929
 

Inpatient Services

Net revenues increased $188.8 million, or 86.6%, to $406.9 million for the three months ended March 31, 2008 from $218.1 million for the three months ended March 31, 2007. The addition of Harborside contributed $169.3 million of the increase.  The remaining increase of $19.5 million or 8.9% was primarily the result of:

-
an increase of $8.0 million in Medicare revenues comprised of a $6.1 million increase in Medicare Part A rates, a $1.2 million increase from a higher customer base and a $0.7 million increase in Medicare Part B revenues;
   
-
an increase of $4.9 million in Medicaid revenues due to improved rates;
   
-
a $4.9 million increase in managed care and commercial insurance revenues driven by a higher customer base, which contributed $4.0 million of the increase, and higher rates, which drove the remaining $0.9 million of the increase;
   
-
a $4.5 million increase in private pay revenues due to higher rates and increased customer base which contributed $2.8 million and $1.7 million, respectively, to the increase; and
   
-
an increase of $0.9 million and $0.1 million in hospice and enteral nutrition revenues, respectively;
   
 
Offset in part by:
   
-
a $3.8 million decrease in Medicaid revenues due to lower customer base.

Operating salaries and benefits expenses increased $99.0 million, or 92.3%, to $206.3 million for the three months ended March 31, 2008 from $107.3 million for the three months ended March 31, 2007.  The accretive impact of the Harborside operations contributed $91.6 million of the increase, with the remaining increase of $7.4 million attributable to the following:

-
wage increases and related benefits and taxes of $6.7 million;
   
-
an increase of $0.5 million in health insurance expense; and
 
32

 
-
a $0.8 million increase in overtime expenses;
   
 
Offset in part by:
   
-
a decrease of $0.4 million in paid time-off, including sick, vacation and holiday; and
   
-
a decrease of $0.2 million in bonus expense.
 
Self-insurance for workers’ compensation and general and professional liability insurance increased $4.7 million, or 49.5%, to $14.2 million for the three months ended March 31, 2008 as compared to $9.5 million for the three months ended March 31, 2007.  The addition of Harborside accounted for all of the net increase for the three months ended March 31, 2008, with an increase in workers’ compensation expense offsetting a decrease in general liability insurance expense for the other LTC centers.

Other operating costs increased $45.8 million, or 77.5%, to $104.9 million for the three months ended March 31, 2008 from $59.1 million for the three months ended March 31, 2007.  Approximately $40.3 million of this amount was due to the addition of Harborside.  The remaining increase of $5.5 million was primarily due to:

-
a $3.1 million increase in therapy and equipment rental costs due to an increase in higher acuity patients requiring more rehabilitation therapy;
   
-
a $1.5 million increase in supplies, due to higher costs for medical, incontinency and food supplies;
   
-
a $0.8 million increase in education and training;
   
-
a $0.5 million increase in utilities expense;
   
-
a $0.5 million increase in legal fees; and
   
-
a $0.2 million increase in civil monetary penalties;
   
 
Offset in part by:
   
-
a $0.5 million decrease in contract labor;
   
-
a $0.3 million decrease in professional and consultant fees; and
   
-
a $0.3 million decrease in taxes primarily related to gross receipts and real estate taxes.

General and administrative expenses increased $4.2 million, or 79.2%, to $9.5 million for the three months ended March 31, 2008 from $5.3 million for the three months ended March 31, 2007. The addition of the Harborside operations accounted for $3.2 million of the increase with the remaining $1.0 million due primarily to the filling of open positions and travel.

The provision for losses on accounts receivable increased $0.8 million, or 38.1%, to approximately $2.9 million for the three months ended March 31, 2008 from $2.1 million for the three months ended March 31, 2007. The increase was primarily attributable to the addition of the Harborside operations.

Center rent expense of $18.5 million for the three months ended March 31, 2008 increased $5.3 million, or 40.2%, compared to $13.2 million for the three months ended March 31, 2007, due to $4.7 million of rent expense associated with the acquired Harborside operations and $0.6 million of rent increases at Sun centers.

Depreciation and amortization increased $5.5 million, or 171.9%, to $8.7 million for the three months ended March 31, 2008 from $3.2 million for the three months ended March 31, 2007. The increase was primarily attributable to the addition

 
33

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
of the Harborside centers and additional depreciation expense on Sun centers for new property, plant and equipment acquired during the year.

Net interest expense for the three months ended March 31, 2008 was $3.3 million as compared to $2.5 million for the three months ended March 31, 2007.  The increase of $0.8 million, or 32.0%, was primarily due to debt incurred and assumed in the Harborside acquisition.

Rehabilitation Therapy Services

Total revenues from the Rehabilitation Therapy Services segment increased $5.1 million, or 16.5%, to $36.0 million for the three months ended March 31, 2008 from $30.9 million for the three months ended March 31, 2007. The revenue increase was the result of:

-
an increase of $3.1 million attributable to a 9.5% increase in billable minutes; the volume increase being due to an increase in contract count and an overall increase in service volume, mainly in the affiliated LTC center segment and non-affiliated rehabilitation agencies; and
   
-
an increase of $2.0 million attributable to a 6.0% increase in our billing rate due to our renegotiation of certain non-affiliated customer contract rates and an increase in all of our affiliated contract rates.
   
Operating salaries and benefits expenses increased $3.9 million, or 15.0%, to $29.9 million for the three months ended March 31, 2008 from $26.0 million for the three months ended March 31, 2007. The increase was primarily driven by wage rate increases coupled with the aforementioned increase in business volume.

Medical Staffing Services

Total revenues from the Medical Staffing Services segment increased $6.3 million, or 26.4%, to $30.2 million for the three months ended March 31, 2008 from $23.9 million for the three months ended March 31, 2007.  The increase was primarily the result of:

-
an increase of $3.2 million attributable to a 14.2% increase in billable hours;
   
-
an increase of $0.7 million due to an average bill rate per hour increase;
   
-
an increase of $0.6 million due to an increase in temporary placement of physicians; and
 
-
an increase of $2.1 million due to addition of Harborside’s medical staffing business;
 
 
Offset in part by:
   
-
a decrease of  $0.6 million related to disposed offices.

Operating salaries and benefits expenses were $22.5 million for the three months ended March 31, 2008 as compared to $18.9 million for the three months ended March 31, 2007, an increase of $3.6 million, or 19.0%. The increase in operating salaries and benefits resulted from the increase in business.

Other operating costs increased $2.1 million, or 116.7%, to $3.9 million for the three months ended March 31, 2008 from $1.8 million for the three months ended March 31, 2007. The increase was primarily attributable to costs paid for travel and lodging.

Corporate

General and administrative expenses not directly attributed to segments increased $3.8 million, or 29.7%, to $16.6 million for the three months ended March 31, 2008 from $12.8 million for the three months ended March 31, 2007. The increase was primarily due to costs incurred for various process improvements and other initiatives.  As a percent of

 
34

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
consolidated revenues, general and administrative expenses were 3.6% for the three months ended March 31, 2008 compared to 4.9% for the three months ended March 31, 2007.

Interest expense

Interest expense not directly attributed to operating segments increased $11.5 million to $11.1 million for the three months ended March 31, 2008.  For the three months ended March 31, 2007, our interest expense was more than offset by our interest income, resulting in net interest income of $0.4 million. The increase in expense was due to the debt incurred and assumed in the Harborside acquisition.

Liquidity and Capital Resources

For the three months ended March 31, 2008, our net income was $8.6 million.  As of March 31, 2008, our working capital was $97.8 million. As of March 31, 2008, we had cash and cash equivalents of $62.9 million, $726.3 million in borrowings and $50.0 million available under our revolving credit facility.

We believe that our operating cash flows, existing cash reserves and availability for borrowing under our revolving credit facility will provide sufficient funds for our operations, capital expenditures and regularly scheduled debt service payments at least through the next twelve months. We do not depend on cash flows from discontinued operations to provide for future liquidity.

Cash Flows

During the three months ended March 31, 2008, net cash provided by operating activities increased by $11.2 million as compared to the same period last year. This increase was the result of (i) our quarter-over-quarter increase in net income of $4.7 million, (ii) our quarter-over-quarter decrease in working capital changes of $1.5 million and (iii) a $8.0 million increase in non-cash adjustments to net income, principally related to depreciation and amortization expenses.

Credit Agreement

We have entered into a Credit Agreement with a group of lenders for which Credit Suisse acts as administrative agent and collateral agent (the “Credit Agreement”).  The Credit Agreement, which is collateralized by substantially all of our assets, provides for $365.0 million in term loans (all of which have been funded and $349.0 million of which was outstanding as of March 31, 2008 - see Note 4 – “Long-Term Debt and Capital Lease Obligations”), a $50.0 million revolving credit facility and a $70.0 million letter of credit facility.  The final maturity date of the term loans is April 19, 2014, and the revolving credit facility and letter of credit facility terminate on April 19, 2013.  Availability of amounts under the revolving credit facility is subject to compliance with financial covenants including an interest coverage test, a total leverage covenant and a senior leverage covenant.  The Credit Agreement contains customary events of default, such as our failure to make payment of amounts due, defaults under other agreements evidencing indebtedness, certain bankruptcy events and a change of control (as defined in the Credit Agreement). The Credit Agreement also contains customary covenants restricting, among other things, incurrence of indebtedness, liens, payment of dividends, repurchase of stock, acquisitions and dispositions, mergers and investments.

Amounts borrowed under the term loan facilities are due in quarterly installments of 0.25% of the aggregate principal amount of the term loans under the term loan facility outstanding as of January 15, 2008, with the remaining principal amount due on the maturity date of the term loans.  Accrued interest is payable at the end of an interest period, but no less frequently than every three months.  The loans under the Credit Agreement bear interest on the outstanding unpaid principal amount at a rate equal to an applicable percentage plus, at our option, either (a) an alternative base rate determined by reference to the higher of (i) the prime rate announced by Credit Suisse and (ii) the federal funds rate plus one-half of 1.0%, or (b) the London Interbank Offered Rate (“LIBOR”), adjusted for statutory reserves.  The applicable percentage for term loans is 1.0% for alternative base rate loans and 2.0% for LIBOR loans; and the applicable percentage for revolving loans is up to 1.0% for alternative base rate revolving loans and up to 2.0% for LIBOR rate revolving loans based on our total leverage ratio.   Each year, commencing in 2009, within 90 days of the prior fiscal year end, we are required to prepay a portion of the term loans in an amount based on the prior year’s excess cash flows, if any, as defined in the Credit Agreement.

 
35

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES
 
Other Debt

We have issued $200.0 million aggregate principal amount of 9-1/8% Senior Subordinated Notes (the “Notes”). The Notes, of which $200.0 million remain outstanding, are unconditionally guaranteed on a senior subordinated basis by certain of our subsidiaries and are unsecured by any assets (see Note 12 – “Summarized Consolidating Information”).  The Notes mature on April 15, 2015, and we are entitled to redeem some or all of the Notes at any time on or after April 15, 2011 at certain pre-specified redemption prices.  In addition, prior to April 15, 2011, we may redeem some or all of the Notes at a price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, plus a “make whole” premium as per the terms of the Notes.  We are entitled to redeem up to 35% of the aggregate principal amount of the Notes until April 15, 2010 with the net proceeds from certain equity offerings at certain pre-specified redemption prices.  The Notes accrue interest at an annual rate of 9-1/8%.  The Notes pay interest semi-annually on April 15th and October 15th of each year through the April 15, 2015 maturity date of the Notes.

We have entered into an interest rate swap agreement for interest rate risk management purposes.  The interest rate swap agreement effectively modifies our exposure to increases in interest rates by converting a portion of our floating rate debt to a fixed rate.  This agreement involves the receipt of floating rate amounts in exchange for fixed rate interest payments over the life of the agreement without an exchange of the underlying principal amount.  The agreement is based on a notional amount of $100 million and terminates in July 2010.  Settlement occurs on a quarterly basis, which is based upon floating rate of LIBOR and an annual fixed rate of 5.388%.  At March 31, 2008, and December 31, 2007, the fair value of the interest rate swap agreement was a liability of $6.9 million and $4.0 million, respectively, which is based upon quoted prices in active markets for identical arrangements.

The interest rate swap agreement qualifies for hedge accounting treatment under SFAS No. 133 and has been designated as a cash flow hedge.  Hedge effectiveness testing for the three months ended March 31, 2008, indicates that the swap is a fully effective hedge and as such, the derivative mark-to-market adjustment increased our other comprehensive loss by $1.7 million, net of related tax benefit.  The full balance of accumulated other comprehensive loss is due to accounting for our interest rate swap.  We do not anticipate any of this amount to be reclassified into earnings within the next year.  Also, since the swap is a fully effective hedging arrangement, there is no amount related to hedging ineffectiveness to expense.

Our net long-term debt of $726.3 million includes $49.2 million of debt of our nine partnerships and limited liability companies (collectively known as “Clipper”). We own 34% of the equity interests of Clipper, but due to our consolidation of the Clipper entities as variable interest entities, we include all of the Clipper indebtedness on our balance sheet (see Note 7 – “Variable Interest Entities”).  Of the $31.8 million current portion of long-term debt as of March 31, 2008, $0.8 million represents Clipper debt.

We have no other off balance sheet arrangements.

Capital Expenditures

We incurred total net capital expenditures related primarily to improvements at existing centers, as reflected in the segment reporting, of $5.9 million and $7.3 million for the three months ended March 31, 2008 and 2007, respectively.


 
36

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risk because we hold debt that is sensitive to changes in interest rates. We manage our interest rate risk exposure by maintaining a mix of fixed and variable rates for debt. The following table provides information regarding our market sensitive financial instruments and constitutes a forward-looking statement.
 
                                             
Fair Value
   
Fair Value
 
   
Expected Maturity Dates
         
March 31,
   
December 31,
 
   
2009
   
2010
   
2011
   
2012
   
2013
   
Thereafter
   
Total
   
2008 (1)
   
2007 (1)
 
   
(Dollars in thousands)
 
Long-term Debt:
                                                     
Fixed rate debt (2)
$
26,310
 
$
5,347
 
$
13,239
 
$
34,002
 
$
5,149
 
$
389,494
 
$
473,541
 
$
437,867
 
$
428,428
 
Rate
 
7.6
%
 
8.2
%
 
8.4
%
 
6.9
%
 
8.3
%
 
8.3
%
                 
                                                       
Variable rate debt
$
6,253
 
$
2,499
 
$
2,499
 
$
2,499
 
$
2,499
 
$
236,490
 
$
252,739
 
$
239,901
 
$
248,128
 
Rate
 
7.0
%
 
5.3
%
 
5.3
%
 
5.3
%
 
5.3
%
 
5.3
%
                 
                                                       
Interest rate swap:
                                                     
Variable to fixed
$
100,000
 
$
100,000
   
-
   
-
   
-
   
-
       
$
(6,873
)
 
(4,005
)
Average pay rate
 
5.39
%
 
5.39
%
 
-
   
-
   
-
   
-
                   
Average receive rate
 
3.70
%
 
3.70
%
 
-
   
-
   
-
   
-
                   
 
(1)
The fair value of fixed and variable rate debt was determined based on the current rates offered for debt with similar risks and maturities.
   
(2)
Fixed rate long-term debt includes $49.2 million related to the consolidation of Clipper as of March 31, 2008 and $49.4 million as of December 31, 2007 (see Note 7 – “Variable Interest Entities”).
 
ITEM 4.  CONTROLS AND PROCEDURES

As of the end of the period covered by this report, our management, including our principal executive officer (Richard Matros) and principal financial officer (L. Bryan Shaul), conducted an evaluation of the effectiveness of our disclosure controls and procedures as of March 31, 2008.  Disclosure controls  and procedures are defined as controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported with the time periods specified in the Securities and Exchange Commission’s rules and forms and include, without limitation, controls and procedures designed to ensure that information is accumulated  and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding  required disclosure.  Based on that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures are effective as of March 31, 2008.  No change in our internal control over financial reporting occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.


PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The Kentucky Attorney General’s office has commenced an investigation that relates to potentially all of our 19 centers in Kentucky, which we acquired in April 2007 in the Harborside acquisition.  We became aware of this investigation after receipt of subpoenas by many of our centers for records of certain of our current and former residents for specified periods of time between 2005 and 2008.  We have not been informed of the precise nature of the investigation, although we are cooperating with the Attorney General’s office.  See Note 10 – “Other Events.”

 
37

 
SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES


ITEM 6. EXHIBITS

31.1
Section 302 Sarbanes-Oxley Certification by Chief Executive Officer
   
31.2
Section 302 Sarbanes-Oxley Certification by Chief Financial Officer
   
32.1
Section 906 Sarbanes-Oxley Certification by Chief Executive Officer
   
32.2
Section 906 Sarbanes-Oxley Certification by Chief Financial Officer


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

SUN HEALTHCARE GROUP, INC.
 
 
 
By:  /s/ L. Bryan Shaul                                        
L. Bryan Shaul
Executive Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)

April 30, 2008

 
38

 

EX-31.1 2 ex31-1.htm EXHIBIT 31.1 ex31-1.htm
EXHIBIT 31.1

CERTIFICATION PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

I, Richard K. Matros, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Sun Healthcare Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date: April 30, 2008
/s/ Richard K. Matros
 
Richard K. Matros
Chief Executive Officer (Principal Executive Officer)



EX-31.2 3 ex31-2.htm EXHIBIT 31.2 ex31-2.htm
EXHIBIT 31.2

CERTIFICATION PURSUANT TO
SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

I, L. Bryan Shaul, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Sun Healthcare Group, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date: April 30, 2008
/s/ L. Bryan Shaul
 
L. Bryan Shaul
Executive Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)



EX-32.1 4 ex32-1.htm EXHIBIT 32.1 ex32-1.htm
EXHIBIT 32.1

WRITTEN STATEMENT
 PURSUANT TO
18 U.S.C. SECTION 1350



   The undersigned, Richard K. Matros, the Chief Executive Officer (Principal Executive Officer), of Sun Healthcare Group, Inc. (the "Company"), pursuant to 18 U.S.C. Section 1350, hereby certifies that:

(i)   the Quarterly Report on Form 10-Q for the quarter ended March 31, 2008 of the Company (the "Report") fully complies with the requirements of section 13(a) and 15(d) of the Securities Exchange Act of 1934; and

(ii)   the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: April 30, 2008
 /s/ Richard K. Matros                                     
 
Richard K. Matros
 
 
 

 


EX-32.2 5 ex32-2.htm EXHIBIT 32.2 ex32-2.htm
EXHIBIT 32.2

WRITTEN STATEMENT
 PURSUANT TO
18 U.S.C. SECTION 1350



   The undersigned, L. Bryan Shaul, the Chief Financial Officer (Principal Financial Officer), of Sun Healthcare Group, Inc. (the "Company"), pursuant to 18 U.S.C. Section 1350, hereby certifies that:

(i)   the Quarterly Report on Form 10-Q for the quarter ended March 31, 2008 of the Company (the "Report") fully complies with the requirements of section 13(a) and 15(d) of the Securities Exchange Act of 1934; and

(ii)   the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: April 30, 2008
  /s/ L. Bryan Shaul                                      
 
L. Bryan Shaul
 

 


-----END PRIVACY-ENHANCED MESSAGE-----